BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Garg A. Acquired and Inherited Lipodystrophies. N Engl J Med 2004;350:1220-34. [DOI: 10.1056/nejmra025261] [Cited by in Crossref: 630] [Cited by in F6Publishing: 669] [Article Influence: 33.2] [Reference Citation Analysis]
Number Citing Articles
1 Su X, Lin Y, Liu L, Mei H, Xu A, Zeng C, Sheng H, Cheng J, Shao Y, Zheng R, Ting TH, Zhang W, Li X. Features of BSCL2 related congenital generalized lipodystrophy in China: long-term follow-up of three patients and literature review. J Pediatr Endocrinol Metab 2023;36:74-80. [PMID: 36433712 DOI: 10.1515/jpem-2022-0372] [Reference Citation Analysis]
2 Calcaterra V, Magenes VC, Rossi V, Fabiano V, Mameli C, Zuccotti G. Lipodystrophies in non-insulin-dependent children: Treatment options and results from recombinant human leptin therapy. Pharmacol Res 2023;187:106629. [PMID: 36566927 DOI: 10.1016/j.phrs.2022.106629] [Reference Citation Analysis]
3 Greeley SAW, Polak M, Njølstad PR, Barbetti F, Williams R, Castano L, Raile K, Chi DV, Habeb A, Hattersley AT, Codner E. ISPAD Clinical Practice Consensus Guidelines 2022: The diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes 2022;23:1188-211. [PMID: 36537518 DOI: 10.1111/pedi.13426] [Reference Citation Analysis]
4 Martin SA, Sanchez RJ, Olayinka-amao O, Harris C, Fehnel S. Qualitative interviews in patients with lipodystrophy to assess the patient experience: evaluation of hunger and other symptoms. J Patient Rep Outcomes 2022;6:84. [DOI: 10.1186/s41687-022-00486-3] [Reference Citation Analysis]
5 Michels MAHM, Volokhina EB, van de Kar NCAJ, van den Heuvel LPJ. Challenges in diagnostic testing of nephritic factors. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1036136] [Reference Citation Analysis]
6 Metz M, Beghini M, Wolf P, Pfleger L, Hackl M, Bastian M, Freudenthaler A, Harreiter J, Zeyda M, Baumgartner-Parzer S, Marculescu R, Marella N, Hannich JT, Györi G, Berlakovich G, Roden M, Krebs M, Risti R, Lõokene A, Trauner M, Kautzky-Willer A, Krššák M, Stangl H, Fürnsinn C, Scherer T. Leptin increases hepatic triglyceride export via a vagal mechanism in humans. Cell Metab 2022;34:1719-1731.e5. [PMID: 36220067 DOI: 10.1016/j.cmet.2022.09.020] [Reference Citation Analysis]
7 Oral EA, Garg A, Tami J, Huang EA, O'Dea LSL, Schmidt H, Tiulpakov A, Mertens A, Alexander VJ, Watts L, Hurh E, Witztum JL, Geary RS, Tsimikas S. Assessment of efficacy and safety of volanesorsen for treatment of metabolic complications in patients with familial partial lipodystrophy: Results of the BROADEN study: Volanesorsen in FPLD; The BROADEN Study. J Clin Lipidol 2022;16:833-49. [PMID: 36402670 DOI: 10.1016/j.jacl.2022.08.008] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Pan L, Xu Q, Liu J, Gao Y, Li J, Peng H, Chen L, Wang M, Mai G, Yang S. Dose–response relationship between Chinese visceral adiposity index and type 2 diabetes mellitus among middle-aged and elderly Chinese. Front Endocrinol 2022;13:959860. [DOI: 10.3389/fendo.2022.959860] [Reference Citation Analysis]
9 Wang Y, Zhang C, Wang Y, Liu X, Zhang Z. Enhancer RNA (eRNA) in Human Diseases. Int J Mol Sci 2022;23:11582. [PMID: 36232885 DOI: 10.3390/ijms231911582] [Reference Citation Analysis]
10 Zhao L, Shen Y, Wang Y, Wang L, Zhang L, Zhao Z, Li S. Lactobacillus plantarum S9 alleviates lipid profile, insulin resistance, and inflammation in high-fat diet-induced metabolic syndrome rats. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-19839-5] [Reference Citation Analysis]
11 Akbari P, Sosina OA, Bovijn J, Landheer K, Nielsen JB, Kim M, Aykul S, De T, Haas ME, Hindy G, Lin N, Dinsmore IR, Luo JZ, Hectors S, Geraghty B, Germino M, Panagis L, Parasoglou P, Walls JR, Halasz G, Atwal GS, Jones M, LeBlanc MG, Still CD, Carey DJ, Giontella A, Orho-Melander M, Berumen J, Kuri-Morales P, Alegre-Díaz J, Torres JM, Emberson JR, Collins R, Rader DJ, Zambrowicz B, Murphy AJ, Balasubramanian S, Overton JD, Reid JG, Shuldiner AR, Cantor M, Abecasis GR, Ferreira MAR, Sleeman MW, Gusarova V, Altarejos J, Harris C, Economides AN, Idone V, Karalis K, Della Gatta G, Mirshahi T, Yancopoulos GD, Melander O, Marchini J, Tapia-Conyer R, Locke AE, Baras A, Verweij N, Lotta LA; Regeneron Genetics Center., DiscovEHR Collaboration. Multiancestry exome sequencing reveals INHBE mutations associated with favorable fat distribution and protection from diabetes. Nat Commun 2022;13:4844. [PMID: 35999217 DOI: 10.1038/s41467-022-32398-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Patni N, Garg A. Lipodystrophy for the Diabetologist-What to Look For. Curr Diab Rep 2022. [PMID: 35821558 DOI: 10.1007/s11892-022-01485-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Chitraju C, Fischer AW, Ambaw YA, Wang K, Yuan B, Hui S, Walther TC, Farese RV. Lipodystrophy can be uncoupled from detrimental metabolic consequences.. [DOI: 10.1101/2022.05.05.490833] [Reference Citation Analysis]
14 Mainieri F, Tagi VM, Chiarelli F. Treatment Options for Lipodystrophy in Children. Front Endocrinol 2022;13:879979. [DOI: 10.3389/fendo.2022.879979] [Reference Citation Analysis]
15 Hummadi A, Nahari AA, Alhagawy AJ, Zakri I, Abutaleb R, Yafei S. Congenital generalized lipodystrophy in two siblings from Saudi Arabia: A case report. Clinical Case Reports 2022;10. [DOI: 10.1002/ccr3.5720] [Reference Citation Analysis]
16 Iqbal J, Jiang H, Wu H, Li L, Zhou Y, Hu N, Xiao F, Wang T, Xu S, Zhou H. Hereditary severe insulin resistance syndrome: Pathogenesis, pathophysiology, and clinical management. Genes & Diseases 2022. [DOI: 10.1016/j.gendis.2022.03.016] [Reference Citation Analysis]
17 Bansal R, Cochran E, Startzell M, Brown RJ. Clinical effects of sodium glucose transporter type 2 inhibitors in patients with partial lipodystrophy. Endocr Pract 2022:S1530-891X(22)00086-6. [PMID: 35301125 DOI: 10.1016/j.eprac.2022.03.006] [Reference Citation Analysis]
18 Pujia R, Tarsitano MG, Arturi F, De Lorenzo A, Lenzi A, Pujia A, Montalcini T. Advances in Phenotyping Obesity and in Its Dietary and Pharmacological Treatment: A Narrative Review. Front Nutr 2022;9:804719. [DOI: 10.3389/fnut.2022.804719] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Mcgrath C, Little-letsinger SE, Sankaran JS, Sen B, Xie Z, Styner MA, Zong X, Chen W, Rubin J, Klett EL, Coleman RA, Styner M. Exercise Increases Bone in SEIPIN Deficient Lipodystrophy, Despite Low Marrow Adiposity. Front Endocrinol 2022;12:782194. [DOI: 10.3389/fendo.2021.782194] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Ferrari F, Calabrò PF, Ceccarini G, Santini F. Eating Behavior and Psychopathology in Non-HIV Lipodystrophic Patients. Hidden and Lesser-known Disordered Eating Behaviors in Medical and Psychiatric Conditions 2022. [DOI: 10.1007/978-3-030-81174-7_35] [Reference Citation Analysis]
21 de Sousa VC, Brasileiro A, Borges AS, Pinheiro R, Oliveira A. Subcutaneous Fat. Atlas of Dermatology, Dermatopathology and Venereology 2022. [DOI: 10.1007/978-3-319-53808-2_42] [Reference Citation Analysis]
22 Rose C. Diseases of Fat. Braun-Falco´s Dermatology 2022. [DOI: 10.1007/978-3-662-63709-8_77] [Reference Citation Analysis]
23 Vinod V, Boudina S. Autophagy in adipose tissue. Autophagy in Health and Disease 2022. [DOI: 10.1016/b978-0-12-822003-0.00018-8] [Reference Citation Analysis]
24 Acharya S, Kandel S, Shrestha S, Tiwari SB, Sapkota S, Bhattarai A, Jha S. Barraquer-Simons syndrome in systemic lupus erythematosus: A case report. Clin Case Rep 2021;9:e05132. [PMID: 34849231 DOI: 10.1002/ccr3.5132] [Reference Citation Analysis]
25 Marques P, Korbonits M. Approach to the Patient with Pseudoacromegaly. J Clin Endocrinol Metab 2021:dgab789. [PMID: 34792134 DOI: 10.1210/clinem/dgab789] [Reference Citation Analysis]
26 Akinci G, Celik M, Akinci B. Complications of lipodystrophy syndromes. Presse Med 2021;50:104085. [PMID: 34728268 DOI: 10.1016/j.lpm.2021.104085] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Khanna S, Bishnoi M, Kondepudi KK, Shukla G. Synbiotic (Lactiplantibacillus pentosus GSSK2 and isomalto-oligosaccharides) supplementation modulates pathophysiology and gut dysbiosis in experimental metabolic syndrome. Sci Rep 2021;11:21397. [PMID: 34725349 DOI: 10.1038/s41598-021-00601-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
28 Meral R, Malandrino N, Walter M, Neidert AH, Muniyappa R, Oral EA, Brown RJ. Endogenous Leptin Concentrations Poorly Predict Metreleptin Response in Patients with Partial Lipodystrophy. J Clin Endocrinol Metab 2021:dgab760. [PMID: 34677608 DOI: 10.1210/clinem/dgab760] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Carneiro VF, Barbosa MC, Martelli DRB, Bonan PR, Aguiar MJB, Martelli Júnior H. A review of genetic syndromes associated with hypertrichosis. Rev Assoc Med Bras 2021;67:1508-1514. [DOI: 10.1590/1806-9282.20210666] [Reference Citation Analysis]
30 Jéru I. Genetics of lipodystrophy syndromes. Presse Med 2021;50:104074. [PMID: 34562561 DOI: 10.1016/j.lpm.2021.104074] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Ceccarini G, Magno S, Gilio D, Pelosini C, Santini F. Autoimmunity in lipodystrophy syndromes. Presse Med 2021;50:104073. [PMID: 34547374 DOI: 10.1016/j.lpm.2021.104073] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Sorkina E, Chichkova V. Generalized lipoatrophy syndromes. Presse Med 2021;50:104075. [PMID: 34562560 DOI: 10.1016/j.lpm.2021.104075] [Reference Citation Analysis]
33 Angelidi AM, Filippaios A, Mantzoros CS. Severe insulin resistance syndromes. J Clin Invest 2021;131:142245. [PMID: 33586681 DOI: 10.1172/JCI142245] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
34 Freire EBL, d'Alva CB, Madeira MP, Lima GEDCP, Montenegro APDR, Fernandes VO, Montenegro Junior RM, Brazilian Group For The Study Of Inherited And Acquired Lipodystrophies Brazlipo. Bone Mineral Density in Congenital Generalized Lipodystrophy: The Role of Bone Marrow Tissue, Adipokines, and Insulin Resistance. Int J Environ Res Public Health 2021;18:9724. [PMID: 34574647 DOI: 10.3390/ijerph18189724] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Melzer F, Geisler C, Schulte DM, Laudes M. Rapid response to leptin therapy in a FPLD patient with a novel PPARG missense variant. Endocrinol Diabetes Metab Case Rep 2021;2021:EDM210082. [PMID: 34515658 DOI: 10.1530/EDM-21-0082] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Gupta C. Bilateral Gluteal Lipodystrophy Following Intramuscular Amikacin Injections. Journal of Postgraduate Medicine, Education and Research 2021;55:132-133. [DOI: 10.5005/jp-journals-10028-1403] [Reference Citation Analysis]
37 Lu CW, Lee YC, Chiang CH, Chang HH, Yang WS, Huang KC. Independent Dose-Response Associations between Fetuin-A and Lean Nonalcoholic Fatty Liver Disease. Nutrients 2021;13:2928. [PMID: 34578806 DOI: 10.3390/nu13092928] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
38 Carrasquilla GD, Christiansen MR, Kilpeläinen TO. The Genetic Basis of Hypertriglyceridemia. Curr Atheroscler Rep 2021;23:39. [PMID: 34146174 DOI: 10.1007/s11883-021-00939-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
39 Lambadiari V, Kountouri A, Maratou E, Liatis S, Dimitriadis GD, Karpe F. Case Report: Metreleptin Treatment in a Patient With a Novel Mutation for Familial Partial Lipodystrophy Type 3, Presenting With Uncontrolled Diabetes and Insulin Resistance. Front Endocrinol (Lausanne) 2021;12:684182. [PMID: 34168618 DOI: 10.3389/fendo.2021.684182] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Other types of diabetes. Handbook of Diabetes 2021. [DOI: 10.1002/9781118976074.ch8] [Reference Citation Analysis]
41 de Candia P, Prattichizzo F, Garavelli S, Alviggi C, La Cava A, Matarese G. The pleiotropic roles of leptin in metabolism, immunity, and cancer. J Exp Med 2021;218:e20191593. [PMID: 33857282 DOI: 10.1084/jem.20191593] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
42 Gomes A, Cook K, Wong A, Tuttle E, Stratton A, Sanders R. Experiences and Perspectives of Patients with Non-HIV-Associated Lipodystrophies and Their Caregivers: A Qualitative Study. Patient 2021;14:673-85. [PMID: 33840079 DOI: 10.1007/s40271-021-00511-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Elsayed AK, Vimalraj S, Nandakumar M, Abdelalim EM. Insulin resistance in diabetes: The promise of using induced pluripotent stem cell technology. World J Stem Cells 2021; 13(3): 221-235 [PMID: 33815671 DOI: 10.4252/wjsc.v13.i3.221] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
44 Araújo-Vilar D, Sánchez-Iglesias S, Castro AI, Cobelo-Gómez S, Hermida-Ameijeiras Á, Rodríguez-Carnero G, Casanueva FF, Fernández-Pombo A. Variable Expressivity in Type 2 Familial Partial Lipodystrophy Related to R482 and N466 Variants in the LMNA Gene. J Clin Med 2021;10:1259. [PMID: 33803652 DOI: 10.3390/jcm10061259] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
45 Cook K, Adamski K, Gomes A, Tuttle E, Kalden H, Cochran E, Brown RJ. Effects of Metreleptin on Patient Outcomes and Quality of Life in Generalized and Partial Lipodystrophy. J Endocr Soc 2021;5:bvab019. [PMID: 33817539 DOI: 10.1210/jendso/bvab019] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
46 Sbraccia P, D'Adamo M, Guglielmi V. Is type 2 diabetes an adiposity-based metabolic disease? From the origin of insulin resistance to the concept of dysfunctional adipose tissue. Eat Weight Disord 2021. [PMID: 33555509 DOI: 10.1007/s40519-021-01109-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
47 de Sousa VC, Brasileiro A, Borges AS, Pinheiro R, Oliveira A. Subcutaneous Fat. Atlas of Dermatology, Dermatopathology and Venereology 2021. [DOI: 10.1007/978-3-319-45134-3_42-1] [Reference Citation Analysis]
48 Han JC, Weiss R. Obesity, Metabolic Syndrome and Disorders of Energy Balance. Sperling Pediatric Endocrinology 2021. [DOI: 10.1016/b978-0-323-62520-3.00024-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
49 Simha V, Garg A. Lipodystrophies. Contemporary Cardiology 2021. [DOI: 10.1007/978-3-030-56514-5_22] [Reference Citation Analysis]
50 Garg A. Genetic Lipodystrophies. Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics 2021. [DOI: 10.1016/b978-0-12-812535-9.00002-9] [Reference Citation Analysis]
51 Winter WE, Pittman DL, Devaraj S, Li D, Harris NS. Evaluation of hyperglycemia. Handbook of Diagnostic Endocrinology 2021. [DOI: 10.1016/b978-0-12-818277-2.00008-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
52 Rose C. Diseases of Fat. Braun-Falco´s Dermatology 2021. [DOI: 10.1007/978-3-662-58713-3_77-1] [Reference Citation Analysis]
53 Knebel B, Müller-Wieland D, Kotzka J. Lipodystrophies-Disorders of the Fatty Tissue. Int J Mol Sci 2020;21:E8778. [PMID: 33233602 DOI: 10.3390/ijms21228778] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
54 Patil AR, Nandikoor S, Jagannath P, Bansal A. Not Just Fat: Imaging in Abdominal Fat Pathology. Journal of Gastrointestinal and Abdominal Radiology 2021;04:049-57. [DOI: 10.1055/s-0040-1718251] [Reference Citation Analysis]
55 Bai X, Huang LJ, Chen SW, Nebenfuehr B, Wysolmerski B, Wu JC, Olson SK, Golden A, Wang CW. Loss of the seipin gene perturbs eggshell formation in Caenorhabditis elegans. Development 2020;147:dev192997. [PMID: 32820022 DOI: 10.1242/dev.192997] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
56 Lopez-Alvarenga JC, Chittoor G, Paul SFD, Puppala S, Farook VS, Fowler SP, Resendez RG, Hernandez-Ruiz J, Diaz-Badillo A, Salazar D, Garza DD, Lehman DM, Mummidi S, Arya R, Jenkinson CP, Lynch JL, DeFronzo RA, Blangero J, Hale DE, Duggirala R. Acanthosis nigricans as a composite marker of cardiometabolic risk and its complex association with obesity and insulin resistance in Mexican American children. PLoS One 2020;15:e0240467. [PMID: 33057385 DOI: 10.1371/journal.pone.0240467] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
57 Banday MZ, Sameer AS, Nissar S. Pathophysiology of diabetes: An overview. Avicenna J Med 2020;10:174-88. [PMID: 33437689 DOI: 10.4103/ajm.ajm_53_20] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
58 Cox AR, Chernis N, Kim KH, Masschelin PM, Saha PK, Briley SM, Sharp R, Felix JB, Moore DD, Pangas SA, Hartig SM. Ubc9 deletion in adipocytes causes lipoatrophy in mice.. [DOI: 10.1101/2020.09.12.294629] [Reference Citation Analysis]
59 Bell D, Iqbal S. Acquired lipodystrophy. Radiopaedia.org 2020. [DOI: 10.53347/rid-80591] [Reference Citation Analysis]
60 García EH, García EB, Casado AN. Development of C3 glomerulopathy in a patient with acquired partial lipodystrophy. Nefrología (English Edition) 2020;40:486-7. [DOI: 10.1016/j.nefroe.2019.08.008] [Reference Citation Analysis]
61 Hernández García E, Borrego García E, Navas-parejo Casado A. Desarrollo de glomerulopatía C3 en paciente con lipodistrofia parcial adquirida. Nefrología 2020;40:486-487. [DOI: 10.1016/j.nefro.2019.08.002] [Reference Citation Analysis]
62 Bedrose S, Turin CG, Lavis VR, Kim ST, Thosani SN. A CASE OF ACQUIRED GENERALIZED LIPODYSTROPHY ASSOCIATED WITH PEMBROLIZUMAB IN A PATIENT WITH METASTATIC MALIGNANT MELANOMA. AACE Clin Case Rep 2020;6:e40-5. [PMID: 32524008 DOI: 10.4158/ACCR-2019-0234] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
63 Sekizkardes H, Cochran E, Malandrino N, Garg A, Brown RJ. Efficacy of Metreleptin Treatment in Familial Partial Lipodystrophy Due to PPARG vs LMNA Pathogenic Variants. J Clin Endocrinol Metab 2019;104:3068-76. [PMID: 31194872 DOI: 10.1210/jc.2018-02787] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
64 Hoa Chung L, Qi Y. Lipodystrophy - A Rare Condition with Serious Metabolic Abnormalities. Rare Diseases 2020. [DOI: 10.5772/intechopen.88667] [Reference Citation Analysis]
65 Rubaie KA, Raef H, Stone DU, Kozak I. Retinopathy and Uveitis in Congenital Generalized Lipodystrophy with Hypertriglyceridemia and Uncontrolled Diabetes (Berardinelli-Seip Syndrome). Middle East Afr J Ophthalmol 2019;26:250-2. [PMID: 32153340 DOI: 10.4103/meajo.MEAJO_94_19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
66 Ceccarini G, Magno S, Pelosini C, Ferrari F, Sessa MR, Scabia G, Maffei M, Jéru I, Lascols O, Vigouroux C, Santini F. Congenital Generalized Lipoatrophy (Berardinelli-Seip Syndrome) Type 1: Description of Novel AGPAT2 Homozygous Variants Showing the Highly Heterogeneous Presentation of the Disease. Front Endocrinol (Lausanne) 2020;11:39. [PMID: 32117065 DOI: 10.3389/fendo.2020.00039] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
67 Purizaca-rosillo ND, Benites-cóndor YE, Abarca Barriga H, del Águila Villar C, Chávez Pastor M, Franco Palacios L, Olea Zapata R, Rejas Parodi J, Martinez Uceda L, Chavesta Velásquez F, Gamarra Vilela J, Arámbulo Castillo S, Ávila Reyes A. High prevalence of congenital generalized lipodystrophy in Piura, Peru. IRDR 2020;9:58-60. [DOI: 10.5582/irdr.2020.01004] [Reference Citation Analysis]
68 Guerreiro V, Bernardes I, Pereira J, Silva RP, Fernandes S, Carvalho D, Freitas P. Acromegaly with congenital generalized lipodystrophy - two rare insulin resistance conditions in one patient: a case report. J Med Case Rep 2020;14:34. [PMID: 32079542 DOI: 10.1186/s13256-020-2352-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
69 Masenga SK, Elijovich F, Hamooya BM, Nzala S, Kwenda G, Heimburger DC, Mutale W, Munsaka SM, Zhao S, Koethe JR, Kirabo A. Elevated Eosinophils as a Feature of Inflammation Associated With Hypertension in Virally Suppressed People Living With HIV. J Am Heart Assoc 2020;9:e011450. [PMID: 32064996 DOI: 10.1161/JAHA.118.011450] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
70 Patni N, Li X, Adams-Huet B, Vasandani C, Gomez-Diaz RA, Garg A. Regional Body Fat Changes and Metabolic Complications in Children With Dunnigan Lipodystrophy-Causing LMNA Variants. J Clin Endocrinol Metab 2019;104:1099-108. [PMID: 30418556 DOI: 10.1210/jc.2018-01922] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
71 Bai X, Huang L, Chen S, Nebenfuehr B, Wysolmerski B, Wu J, Olson SK, Golden A, Wang C. Dietary supplementation with PUFAs rescues the eggshell defects caused by seipin mutations in C. elegans.. [DOI: 10.1101/2020.01.23.916718] [Reference Citation Analysis]
72 von Schnurbein J, Adams C, Akinci B, Ceccarini G, D'Apice MR, Gambineri A, Hennekam RCM, Jeru I, Lattanzi G, Miehle K, Nagel G, Novelli G, Santini F, Santos Silva E, Savage DB, Sbraccia P, Schaaf J, Sorkina E, Tanteles G, Vantyghem MC, Vatier C, Vigouroux C, Vorona E, Araújo-Vilar D, Wabitsch M. European lipodystrophy registry: background and structure. Orphanet J Rare Dis 2020;15:17. [PMID: 31941540 DOI: 10.1186/s13023-020-1295-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
73 Liberato CBR, Olegario NBDC, Fernandes VO, Montenegro APDR, Lima GEDCP, Batista LAA, Martins LV, Penaforte-Saboia JG, Liberato ILR, Lopes LF, d'Alva CB, Furtado FLB, Lima RLM, Nóbrega LHC, Lima JG, Montenegro Junior RM; Brazilian Group for the Study of Inherited and Acquired Lipodystrophies (BRAZLIPO). Early Left Ventricular Systolic Dysfunction Detected by Two-Dimensional Speckle-Tracking Echocardiography in Young Patients with Congenital Generalized Lipodystrophy. Diabetes Metab Syndr Obes 2020;13:107-15. [PMID: 32021357 DOI: 10.2147/DMSO.S233667] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
74 Corvillo F, Ceccarini G, Nozal P, Magno S, Pelosini C, Garrido S, López-Lera A, Moraru M, Vilches C, Fornaciari S, Gabbriellini S, Santini F, Araújo-Vilar D, López-Trascasa M. Immunological features of patients affected by Barraquer-Simons syndrome. Orphanet J Rare Dis 2020;15:9. [PMID: 31924231 DOI: 10.1186/s13023-019-1292-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
75 Mochel MC, Marques MEA, Hoang MP. Panniculitis. Hospital-Based Dermatopathology 2020. [DOI: 10.1007/978-3-030-35820-4_12] [Reference Citation Analysis]
76 Grundy SM. Metabolic Syndrome. Endocrinology 2020. [DOI: 10.1007/978-3-030-36694-0_3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
77 Bai B, Yang W, Fu Y, Foon HL, Tay WT, Yang K, Luo C, Gunaratne J, Lee P, Zile MR, Xu A, Chin CWL, Lam CSP, Han W, Wang Y. Seipin Knockout Mice Develop Heart Failure With Preserved Ejection Fraction. JACC Basic Transl Sci 2019;4:924-37. [PMID: 31909301 DOI: 10.1016/j.jacbts.2019.07.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
78 Purcell C, Taylor SM. Idiopathic facial lipoatrophy in a healthy middle-aged woman: a case report. J Otolaryngol Head Neck Surg 2019;48:63. [PMID: 31727144 DOI: 10.1186/s40463-019-0382-3] [Reference Citation Analysis]
79 Joshi R, Sharma S. Berardinelli Seip Congenital Lipodystrophy Syndrome: 10 Year Follow-up. Indian Pediatr 2019;56:877-8. [DOI: 10.1007/s13312-019-1617-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
80 Özen S, Akıncı B, Oral EA. Current Diagnosis, Treatment and Clinical Challenges in the Management of Lipodystrophy Syndromes in Children and Young People. J Clin Res Pediatr Endocrinol 2020;12:17-28. [PMID: 31434462 DOI: 10.4274/jcrpe.galenos.2019.2019.0124] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
81 Lakra P, Aditi K, Agrawal N. Peripheral Expression of Mutant Huntingtin is a Critical Determinant of Weight Loss and Metabolic Disturbances in Huntington's Disease. Sci Rep 2019;9:10127. [PMID: 31300691 DOI: 10.1038/s41598-019-46470-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
82 Reid MJA, Ma Y, Golovaty I, Okello S, Sentongo R, Feng M, Tsai AC, Kakuhikire B, Tracy R, Hunt PW, Siedner M, Tien PC. Association of Gut Intestinal Integrity and Inflammation with Insulin Resistance in Adults Living with HIV in Uganda. AIDS Patient Care STDS 2019;33:299-307. [PMID: 31188016 DOI: 10.1089/apc.2019.0032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
83 Zou W, Rohatgi N, Brestoff JR, Zhang Y, Scheller EL, Craft CS, Brodt MD, Migotsky N, Silva MJ, Harris CA, Teitelbaum SL. Congenital lipodystrophy induces severe osteosclerosis. PLoS Genet 2019;15:e1008244. [PMID: 31233501 DOI: 10.1371/journal.pgen.1008244] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
84 Hackl MT, Fürnsinn C, Schuh CM, Krssak M, Carli F, Guerra S, Freudenthaler A, Baumgartner-Parzer S, Helbich TH, Luger A, Zeyda M, Gastaldelli A, Buettner C, Scherer T. Brain leptin reduces liver lipids by increasing hepatic triglyceride secretion and lowering lipogenesis. Nat Commun 2019;10:2717. [PMID: 31222048 DOI: 10.1038/s41467-019-10684-1] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 13.0] [Reference Citation Analysis]
85 Corvillo F, Okrój M, Nozal P, Melgosa M, Sánchez-Corral P, López-Trascasa M. Nephritic Factors: An Overview of Classification, Diagnostic Tools and Clinical Associations. Front Immunol 2019;10:886. [PMID: 31068950 DOI: 10.3389/fimmu.2019.00886] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 8.5] [Reference Citation Analysis]
86 Shin KA. Comparison of the Serum Gamma-Glutamyl Transferase and Serum Uric Acid Levels according to the Obesity Types Based upon on the Body Mass Index in Korean Men. Korean J Clin Lab Sci 2019;51:50-56. [DOI: 10.15324/kjcls.2019.51.1.50] [Reference Citation Analysis]
87 Esfandiari NH, Rubenfire M, Neidert AH, Hench R, Eldin AJ, Meral R, Oral EA. Diagnosis of acquired generalized lipodystrophy in a single patient with T-cell lymphoma and no exposure to Metreleptin. Clin Diabetes Endocrinol 2019;5:4. [PMID: 30923630 DOI: 10.1186/s40842-019-0076-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
88 Jiao Y, Ahmed U, Sim MFM, Bejar A, Zhang X, Talukder MMU, Rice R, Flannick J, Podgornaia AI, Reilly DF, Engreitz JM, Kost-Alimova M, Hartland K, Mercader JM, Georges S, Wagh V, Tadin-Strapps M, Doench JG, Edwardson JM, Rochford JJ, Rosen ED, Majithia AR. Discovering metabolic disease gene interactions by correlated effects on cellular morphology. Mol Metab 2019;24:108-19. [PMID: 30940487 DOI: 10.1016/j.molmet.2019.03.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
89 Oral EA, Gorden P, Cochran E, Araújo-Vilar D, Savage DB, Long A, Fine G, Salinardi T, Brown RJ. Long-term effectiveness and safety of metreleptin in the treatment of patients with partial lipodystrophy. Endocrine 2019;64:500-11. [PMID: 30805888 DOI: 10.1007/s12020-019-01862-8] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 11.0] [Reference Citation Analysis]
90 Nakamura Y, Abe M, Kawasaki K, Miyake T, Watanabe T, Yoshida O, Hirooka M, Matsuura B, Hiasa Y. Depletion of B cell-activating factor attenuates hepatic fat accumulation in a murine model of nonalcoholic fatty liver disease. Sci Rep 2019;9:977. [PMID: 30700810 DOI: 10.1038/s41598-018-37403-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
91 Malandrino N, Reynolds JC, Brychta RJ, Chen KY, Auh S, Gharib AM, Startzell M, Cochran EK, Brown RJ. Visceral fat does not contribute to metabolic disease in lipodystrophy. Obes Sci Pract 2019;5:75-82. [PMID: 30847226 DOI: 10.1002/osp4.319] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
92 Elias CP, Antunes DE, Coelho MS, de Lima CL, Rassi N, de Melo APM, Amato AA. Evaluation of the hypothalamic-pituitary-adrenal axis in a case series of familial partial lipodystrophy. Diabetol Metab Syndr 2019;11:1. [PMID: 30622652 DOI: 10.1186/s13098-018-0396-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
93 Lakra P, Agrawal N. Metabolic Alterations Amalgamated with Huntington’s Disease. Insights into Human Neurodegeneration: Lessons Learnt from Drosophila 2019. [DOI: 10.1007/978-981-13-2218-1_6] [Reference Citation Analysis]
94 El-darouti MA, Al-ali FM. Loss of Subcutaneous Fat, Muscle Hypertrophy, Diabetes and Hyperlipidemia. Challenging Cases in Dermatology Volume 2 2019. [DOI: 10.1007/978-3-030-21855-3_2] [Reference Citation Analysis]
95 Grundy SM. Metabolic Syndrome. Endocrinology 2019. [DOI: 10.1007/978-3-319-27316-7_3-2] [Reference Citation Analysis]
96 Sadeghi S, Saleh E, Danino MA. Lipoatrophy Associated With Maxillary Bone Graft for the Purpose of Dental Implants and Correction by Fat Grafting: A Case Report. Plastic Surgery Case Studies 2019;5:2513826X1987946. [DOI: 10.1177/2513826x19879467] [Reference Citation Analysis]
97 Hussain I, Patni N, Garg A. Lipodystrophies, dyslipidaemias and atherosclerotic cardiovascular disease. Pathology 2019;51:202-12. [PMID: 30595509 DOI: 10.1016/j.pathol.2018.11.004] [Cited by in Crossref: 49] [Cited by in F6Publishing: 35] [Article Influence: 9.8] [Reference Citation Analysis]
98 Lotta LA, Wittemans LBL, Zuber V, Stewart ID, Sharp SJ, Luan J, Day FR, Li C, Bowker N, Cai L, De Lucia Rolfe E, Khaw KT, Perry JRB, O'Rahilly S, Scott RA, Savage DB, Burgess S, Wareham NJ, Langenberg C. Association of Genetic Variants Related to Gluteofemoral vs Abdominal Fat Distribution With Type 2 Diabetes, Coronary Disease, and Cardiovascular Risk Factors. JAMA 2018;320:2553-63. [PMID: 30575882 DOI: 10.1001/jama.2018.19329] [Cited by in Crossref: 112] [Cited by in F6Publishing: 111] [Article Influence: 22.4] [Reference Citation Analysis]
99 Akinci B, Meral R, Oral EA. Update on Therapeutic Options in Lipodystrophy. Curr Diab Rep 2018;18:139. [PMID: 30370487 DOI: 10.1007/s11892-018-1100-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
100 Zhang Y, Federation AJ, Kim S, O'Keefe JP, Lun M, Xiang D, Brown JD, Steinhauser ML. Targeting nuclear receptor NR4A1-dependent adipocyte progenitor quiescence promotes metabolic adaptation to obesity. J Clin Invest 2018;128:4898-911. [PMID: 30277475 DOI: 10.1172/JCI98353] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
101 Ebadi M, Tandon P, Moctezuma-Velazquez C, Ghosh S, Baracos VE, Mazurak VC, Montano-Loza AJ. Low subcutaneous adiposity associates with higher mortality in female patients with cirrhosis. J Hepatol 2018;69:608-16. [PMID: 29709682 DOI: 10.1016/j.jhep.2018.04.015] [Cited by in Crossref: 72] [Cited by in F6Publishing: 70] [Article Influence: 14.4] [Reference Citation Analysis]
102 Srinivasaraghavan R. Barraquer Simons Syndrome - Rare Cause of Progressive Wasting in an Eight Year Old Girl. SBV Journal of Basic, Clinical and Applied Health Science 2018;1:139-140. [DOI: 10.5005/jp-journals-10082-01138] [Reference Citation Analysis]
103 Lotta LA, Dong L, Li C, Patel S, Stewart ID, Lim K, Day FR, Wheeler E, Glastonbury CA, Van de Streek M, Sharp SJ, Luan J, Bowkera N, Schweiger M, Wittemans LBL, Kerrison ND, Cai L, Lucarelli DME, Barroso I, Mccarthy MI, Scott RA, Zechner R, Perry JRB, Saudek V, Small KS, O’rahilly S, Wareham NJ, Savage DB, Langenberg C. Genome-wide scan and fine-mapping of rare nonsynonymous associations implicates intracellular lipolysis genes in fat distribution and cardio-metabolic risk.. [DOI: 10.1101/372128] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
104 Rodriguez-Cuenca S, Carobbio S, Barceló-Coblijn G, Prieur X, Relat J, Amat R, Campbell M, Dias AR, Bahri M, Gray SL, Vidal-Puig A. P465L-PPARγ mutation confers partial resistance to the hypolipidaemic action of fibrates. Diabetes Obes Metab 2018;20:2339-50. [PMID: 29790245 DOI: 10.1111/dom.13370] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
105 Girousse A, Virtue S, Hart D, Vidal-Puig A, Murgatroyd PR, Mouisel E, Sengenès C, Savage DB. Surplus fat rapidly increases fat oxidation and insulin resistance in lipodystrophic mice. Mol Metab 2018;13:24-9. [PMID: 29789270 DOI: 10.1016/j.molmet.2018.05.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
106 Corvillo F, López-trascasa M. Acquired partial lipodystrophy and C3 glomerulopathy: Dysregulation of the complement system as a common mechanism. Nefrología (English Edition) 2018;38:258-266. [DOI: 10.1016/j.nefroe.2018.04.002] [Reference Citation Analysis]
107 Araújo-Vilar D, Santini F. Diagnosis and treatment of lipodystrophy: a step-by-step approach. J Endocrinol Invest 2019;42:61-73. [PMID: 29704234 DOI: 10.1007/s40618-018-0887-z] [Cited by in Crossref: 73] [Cited by in F6Publishing: 79] [Article Influence: 14.6] [Reference Citation Analysis]
108 Gallo-Ebert C, Francisco J, Liu HY, Draper R, Modi K, Hayward MD, Jones BK, Buiakova O, McDonough V, Nickels JT Jr. Mice lacking ARV1 have reduced signs of metabolic syndrome and non-alcoholic fatty liver disease. J Biol Chem 2018;293:5956-74. [PMID: 29491146 DOI: 10.1074/jbc.RA117.000800] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
109 Brown RJ, Oral EA, Cochran E, Araújo-Vilar D, Savage DB, Long A, Fine G, Salinardi T, Gorden P. Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy. Endocrine 2018;60:479-89. [PMID: 29644599 DOI: 10.1007/s12020-018-1589-1] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 10.0] [Reference Citation Analysis]
110 Damasceno ÉDB, Figueiredo JGD, França JMB, Veras JCD, Borges REA, Melo LPD. Experiência de pessoas que vivem com a Síndrome de Berardinelli-Seip no Nordeste brasileiro. Ciênc saúde coletiva 2018;23:389-398. [DOI: 10.1590/1413-81232018232.16802017] [Reference Citation Analysis]
111 Rose C. Erkrankungen des Fettgewebes. Braun-Falco’s Dermatologie, Venerologie und Allergologie 2018. [DOI: 10.1007/978-3-662-49544-5_77] [Reference Citation Analysis]
112 Sergeeva E. Peroxisome Proliferator-Activated Receptor-γ. Encyclopedia of Signaling Molecules 2018. [DOI: 10.1007/978-3-319-67199-4_101879] [Reference Citation Analysis]
113 Grundy SM. Metabolic Syndrome. Endocrinology 2018. [DOI: 10.1007/978-3-319-44433-8_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
114 Grundy SM. Metabolic Syndrome. Endocrinology 2018. [DOI: 10.1007/978-3-319-27316-7_3-1] [Reference Citation Analysis]
115 Rose C. Erkrankungen des Fettgewebes. Braun-Falco's Dermatologie, Venerologie und Allergologie 2018. [DOI: 10.1007/978-3-662-49546-9_77-1] [Reference Citation Analysis]
116 Quaglia A, Roberts EA, Torbenson M. Developmental and Inherited Liver Disease. Macsween's Pathology of the Liver 2018. [DOI: 10.1016/b978-0-7020-6697-9.00003-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
117 Argo CK, Henry ZH, Caldwell SH. Nonalcoholic Fatty Liver Disease. Schiff's Diseases of the Liver 2017. [DOI: 10.1002/9781119251316.ch32] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
118 de Azevedo Medeiros LB, Cândido Dantas VK, Craveiro Sarmento AS, Agnez-Lima LF, Meireles AL, Xavier Nobre TT, de Lima JG, de Melo Campos JTA. High prevalence of Berardinelli-Seip Congenital Lipodystrophy in Rio Grande do Norte State, Northeast Brazil. Diabetol Metab Syndr 2017;9:80. [PMID: 29046728 DOI: 10.1186/s13098-017-0280-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
119 Miehle K, Stumvoll M, Fasshauer M, Hierl T. Facial soft tissue volume decreases during metreleptin treatment in patients with partial and generalized lipodystrophy. Endocrine 2017;58:262-6. [PMID: 28993984 DOI: 10.1007/s12020-017-1437-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
120 Sharawat IK, Dawman L. Localized Lipodystrophy following Single Dose Intramuscular Gentamycin Injection. Indian Dermatol Online J 2017;8:373-4. [PMID: 28979879 DOI: 10.4103/idoj.IDOJ_390_16] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
121 Chiquette E, Oral EA, Garg A, Araújo-Vilar D, Dhankhar P. Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges. Diabetes Metab Syndr Obes 2017;10:375-83. [PMID: 29066925 DOI: 10.2147/DMSO.S130810] [Cited by in Crossref: 55] [Cited by in F6Publishing: 58] [Article Influence: 9.2] [Reference Citation Analysis]
122 Baba Y, Kaneko H, Takemoto M, Ide K, Haga Y, Kanda T, Akita S, Kubota Y, Kuroda M, Kitagawa Y, Yokote K. Case of lipoatrophic diabetes induced by juvenile dermatomyositis. J Diabetes Investig 2017. [PMID: 28895299 DOI: 10.1111/jdi.12745] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
123 Kobayashi N, Nakahara M, Oka M, Saeki K. Additional attention to combination antiretroviral therapy-related lipodystrophy. World J Virol 2017; 6(3): 49-52 [PMID: 28868242 DOI: 10.5501/wjv.v6.i3.49] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
124 Lee JJ, Pedley A, Therkelsen KE, Hoffmann U, Massaro JM, Levy D, Long MT. Upper Body Subcutaneous Fat Is Associated with Cardiometabolic Risk Factors. Am J Med 2017;130:958-966.e1. [PMID: 28238696 DOI: 10.1016/j.amjmed.2017.01.044] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 4.7] [Reference Citation Analysis]
125 Lee SY, Lee HY, Song JH, Kim GT, Jeon S, Song YJ, Lee JS, Hur JH, Oh HH, Park SY, Shim SM, Yoo HJ, Lee BC, Jiang XC, Choi CS, Park TS. Adipocyte-Specific Deficiency of De Novo Sphingolipid Biosynthesis Leads to Lipodystrophy and Insulin Resistance. Diabetes 2017;66:2596-609. [PMID: 28698261 DOI: 10.2337/db16-1232] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 6.3] [Reference Citation Analysis]
126 Kwan R, Brady GF, Brzozowski M, Weerasinghe SV, Martin H, Park MJ, Brunt MJ, Menon RK, Tong X, Yin L, Stewart CL, Omary MB. Hepatocyte-Specific Deletion of Mouse Lamin A/C Leads to Male-Selective Steatohepatitis. Cell Mol Gastroenterol Hepatol 2017;4:365-83. [PMID: 28913408 DOI: 10.1016/j.jcmgh.2017.06.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
127 Gonzalo MM, Estefania CV. Congenital Generalized Lipodystrophy Type 2 in a Patient From a High-Prevalence Area. J Endocr Soc 2017;1:1012-4. [PMID: 29264552 DOI: 10.1210/js.2017-00141] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
128 Vegiopoulos A, Rohm M, Herzig S. Adipose tissue: between the extremes. EMBO J 2017;36:1999-2017. [PMID: 28623240 DOI: 10.15252/embj.201696206] [Cited by in Crossref: 123] [Cited by in F6Publishing: 125] [Article Influence: 20.5] [Reference Citation Analysis]
129 Fountas A, Giotaki Z, Dounousi E, Liapis G, Bargiota A, Tsatsoulis A, Tigas S. Familial partial lipodystrophy and proteinuric renal disease due to a missense c.1045C > T LMNA mutation. Endocrinol Diabetes Metab Case Rep 2017;2017:17-0049. [PMID: 28620495 DOI: 10.1530/EDM-17-0049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
130 Charó NL, Rodríguez Ceschan MI, Galigniana NM, Toneatto J, Piwien-Pilipuk G. Organization of nuclear architecture during adipocyte differentiation. Nucleus 2016;7:249-69. [PMID: 27416359 DOI: 10.1080/19491034.2016.1197442] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
131 Lightbourne M, Brown RJ. Genetics of Lipodystrophy. Endocrinol Metab Clin North Am 2017;46:539-54. [PMID: 28476236 DOI: 10.1016/j.ecl.2017.01.012] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 5.5] [Reference Citation Analysis]
132 Cuthbertson DJ, Steele T, Wilding JP, Halford JC, Harrold JA, Hamer M, Karpe F. What have human experimental overfeeding studies taught us about adipose tissue expansion and susceptibility to obesity and metabolic complications? Int J Obes (Lond). 2017;41:853-865. [PMID: 28077863 DOI: 10.1038/ijo.2017.4] [Cited by in Crossref: 72] [Cited by in F6Publishing: 76] [Article Influence: 12.0] [Reference Citation Analysis]
133 Sasaki H, Ohkubo K, Kobayashi K, Tajiri Y, Ugi S, Kashwagi A. Novel subtype of congenital partial lipodystrophy with mandibular hypoplasia, sensorineural deafness and short stature of unknown genetic origin. J Diabetes Investig 2017;8:121-2. [PMID: 28054466 DOI: 10.1111/jdi.12536] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
134 Sweet M, Taylor M, Mestroni L. Diseases of the Nuclear Membrane. Cardioskeletal Myopathies in Children and Young Adults 2017. [DOI: 10.1016/b978-0-12-800040-3.00012-1] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
135 Yalamanchi S, Brown T, Dobs A. HIV Infection and Diabetes. Principles of Diabetes Mellitus 2017. [DOI: 10.1007/978-3-319-18741-9_38] [Reference Citation Analysis]
136 Grunberger G, Myneni A, Alfonso B. Syndromes of Extreme Insulin Resistance. Principles of Diabetes Mellitus 2017. [DOI: 10.1007/978-3-319-18741-9_17] [Reference Citation Analysis]
137 Grunberger G, Myneni A, Alfonso B. Syndromes of Extreme Insulin Resistance. Principles of Diabetes Mellitus 2017. [DOI: 10.1007/978-3-319-20797-1_17-2] [Reference Citation Analysis]
138 Chen H. Congenital Generalized Lipodystrophy. Atlas of Genetic Diagnosis and Counseling 2017. [DOI: 10.1007/978-1-4939-2401-1_51] [Reference Citation Analysis]
139 Santos ARJ, Ferreira SP, Benazzi M, Capra M, Medeiros HPA, de Jesus AL, de Almeida MH, de Sá LBPC, Arbex AK. Dunnigan-Type Familial Partial Lipodystrophy: Understanding and Treating the Syndrome. OJEMD 2017;07:22-34. [DOI: 10.4236/ojemd.2017.71003] [Reference Citation Analysis]
140 Misra S, Hattersley AT. Monogenic Causes of Diabetes. Textbook of Diabetes 2016. [DOI: 10.1002/9781118924853.ch18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
141 Purizaca-Rosillo N, Mori T, Benites-Cóndor Y, Hisama FM, Martin GM, Oshima J. High incidence of BSCL2 intragenic recombinational mutation in Peruvian type 2 Berardinelli-Seip syndrome. Am J Med Genet A 2017;173:471-8. [PMID: 27868354 DOI: 10.1002/ajmg.a.38053] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
142 Le Dour C, Wu W, Béréziat V, Capeau J, Vigouroux C, Worman HJ. Extracellular matrix remodeling and transforming growth factor-β signaling abnormalities induced by lamin A/C variants that cause lipodystrophy. J Lipid Res 2017;58:151-63. [PMID: 27845687 DOI: 10.1194/jlr.M071381] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 4.3] [Reference Citation Analysis]
143 Majithia AR, Tsuda B, Agostini M, Gnanapradeepan K, Rice R, Peloso G, Patel KA, Zhang X, Broekema MF, Patterson N, Duby M, Sharpe T, Kalkhoven E, Rosen ED, Barroso I, Ellard S, Kathiresan S, O'Rahilly S, Chatterjee K, Florez JC, Mikkelsen T, Savage DB, Altshuler D; UK Monogenic Diabetes Consortium., Myocardial Infarction Genetics Consortium., UK Congenital Lipodystrophy Consortium. Prospective functional classification of all possible missense variants in PPARG. Nat Genet 2016;48:1570-5. [PMID: 27749844 DOI: 10.1038/ng.3700] [Cited by in Crossref: 162] [Cited by in F6Publishing: 162] [Article Influence: 23.1] [Reference Citation Analysis]
144 Brown RJ, Araujo-Vilar D, Cheung PT, Dunger D, Garg A, Jack M, Mungai L, Oral EA, Patni N, Rother KI, von Schnurbein J, Sorkina E, Stanley T, Vigouroux C, Wabitsch M, Williams R, Yorifuji T. The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline. J Clin Endocrinol Metab 2016;101:4500-11. [PMID: 27710244 DOI: 10.1210/jc.2016-2466] [Cited by in Crossref: 216] [Cited by in F6Publishing: 229] [Article Influence: 30.9] [Reference Citation Analysis]
145 Hussain I, Garg A. Lipodystrophy Syndromes. Endocrinol Metab Clin North Am 2016;45:783-97. [PMID: 27823605 DOI: 10.1016/j.ecl.2016.06.012] [Cited by in Crossref: 96] [Cited by in F6Publishing: 97] [Article Influence: 13.7] [Reference Citation Analysis]
146 Holaska JM. Diseases of the Nucleoskeleton. Compr Physiol 2016;6:1655-74. [PMID: 27783855 DOI: 10.1002/cphy.c150039] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
147 de Lucas-collantes C, Pozo-román J, Aparicio-lópez C, de Prada-vicente I, Argente J. Lipodistrofia parcial adquirida (síndrome de Barraquer-Simons) y nefropatía IgA. Nefrología 2016;36:556-8. [DOI: 10.1016/j.nefro.2016.03.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
148 de Lucas-collantes C, Pozo-román J, Aparicio-lópez C, de Prada-vicente I, Argente J. Acquired partial lipodystrophy (Barraquer–Simons syndrome) and IgA nephropathy. Nefrología (English Edition) 2016;36:556-558. [DOI: 10.1016/j.nefroe.2016.11.001] [Reference Citation Analysis]
149 Pap A, Cuaranta-Monroy I, Peloquin M, Nagy L. Is the Mouse a Good Model of Human PPARγ-Related Metabolic Diseases? Int J Mol Sci 2016;17:E1236. [PMID: 27483259 DOI: 10.3390/ijms17081236] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
150 Panikkath R, Panikkath D, Sanchez-Iglesias S, Araujo-Vilar D, Lado-Abeal J. An Uncommon Association of Familial Partial Lipodystrophy, Dilated Cardiomyopathy, and Conduction System Disease. J Investig Med High Impact Case Rep 2016;4:2324709616658495. [PMID: 27504462 DOI: 10.1177/2324709616658495] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
151 Heidemann LN, Thomsen JB, Sørensen JA. Barraquer-Simons syndrome: a unique patient's perspective on diagnosis, disease progression and recontouring treatment. BMJ Case Rep 2016;2016:bcr2016216134. [PMID: 27402657 DOI: 10.1136/bcr-2016-216134] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
152 Garg A, Sankella S, Xing C, Agarwal AK. Whole-exome sequencing identifies ADRA2A mutation in atypical familial partial lipodystrophy. JCI Insight 2016;1:e86870. [PMID: 27376152 DOI: 10.1172/jci.insight.86870] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
153 Keswell D, Tootla M, Goedecke JH. Associations between body fat distribution, insulin resistance and dyslipidaemia in black and white South African women. Cardiovasc J Afr 2016;27:177-83. [PMID: 27224872 DOI: 10.5830/CVJA-2015-088] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
154 Jéru I, Vatier C, Araujo-Vilar D, Vigouroux C, Lascols O. Clinical Utility Gene Card for: Congenital Generalized Lipodystrophy. Eur J Hum Genet 2016;24. [PMID: 27189019 DOI: 10.1038/ejhg.2016.53] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
155 Shearin AL, Monks BR, Seale P, Birnbaum MJ. Lack of AKT in adipocytes causes severe lipodystrophy. Mol Metab 2016;5:472-9. [PMID: 27408773 DOI: 10.1016/j.molmet.2016.05.006] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 6.1] [Reference Citation Analysis]
156 Tewari V. Congenital Generalized Lipodystrophy: A Multisystemic Metabolic Disorder. Int J Clin Endocrinol Metab 2016. [DOI: 10.17352/ijcem.000013] [Reference Citation Analysis]
157 Chakraborty PP, Datta S, Mukhopadhyay S, Chowdhury S. Pseudoacromegaly in congenital generalised lipodystrophy (Berardinelli-Seip syndrome). BMJ Case Rep 2016;2016:10.1136/bcr-2016-214493. [PMID: 27068725 DOI: 10.1136/bcr-2016-214493] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
158 Bhujel N, Clark H. Case report: Dental management of Berardinelli-Seip congenital lipodystrophy. Eur Arch Paediatr Dent 2016;17:137-140. [DOI: 10.1007/s40368-015-0210-z] [Reference Citation Analysis]
159 Komiya C, Tsuchiya K, Shiba K, Miyachi Y, Furuke S, Shimazu N, Yamaguchi S, Kanno K, Ogawa Y. Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction. PLoS One. 2016;11:e0151511. [PMID: 26977813 DOI: 10.1371/journal.pone.0151511] [Cited by in Crossref: 156] [Cited by in F6Publishing: 165] [Article Influence: 22.3] [Reference Citation Analysis]
160 Lima JG, Nobrega LH, de Lima NN, do Nascimento Santos MG, Baracho MF, Jeronimo SM. Clinical and laboratory data of a large series of patients with congenital generalized lipodystrophy. Diabetol Metab Syndr 2016;8:23. [PMID: 26985241 DOI: 10.1186/s13098-016-0140-x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
161 Granizo-rubio J, Pinos-león V, Madrigal C, Moreno A, Ortiz-prado E. Síndrome de Barraquer-Simons o lipodistrofia parcial adquirida. Piel 2016;31:184-188. [DOI: 10.1016/j.piel.2015.05.005] [Reference Citation Analysis]
162 Chan JL, Koda J, Heilig JS, Cochran EK, Gorden P, Oral EA, Brown RJ. Immunogenicity associated with metreleptin treatment in patients with obesity or lipodystrophy. Clin Endocrinol (Oxf) 2016;85:137-49. [PMID: 26589105 DOI: 10.1111/cen.12980] [Cited by in Crossref: 27] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
163 Levenson AE, Haas ME, Miao J, Brown RJ, de Ferranti SD, Muniyappa R, Biddinger SB. Effect of Leptin Replacement on PCSK9 in ob/ob Mice and Female Lipodystrophic Patients. Endocrinology 2016;157:1421-9. [PMID: 26824363 DOI: 10.1210/en.2015-1624] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
164 Yalamanchi S, Brown T, Dobs A. HIV Infection and Diabetes. Principles of Diabetes Mellitus 2016. [DOI: 10.1007/978-3-319-20797-1_38-1] [Reference Citation Analysis]
165 Tsoukas MA, Mantzoros CS. Lipodystrophy Syndromes. Endocrinology: Adult and Pediatric 2016. [DOI: 10.1016/b978-0-323-18907-1.00037-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
166 Sergeeva E. Peroxisome Proliferator-Activated Receptor-γ. Encyclopedia of Signaling Molecules 2016. [DOI: 10.1007/978-1-4614-6438-9_101879-1] [Reference Citation Analysis]
167 Chen H. Congenital Generalized Lipodystrophy. Atlas of Genetic Diagnosis and Counseling 2016. [DOI: 10.1007/978-1-4614-6430-3_51-2] [Reference Citation Analysis]
168 Ruderman NB, Shulman GI. Metabolic Syndrome. Endocrinology: Adult and Pediatric 2016. [DOI: 10.1016/b978-0-323-18907-1.00043-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
169 Polonsky KS, Burant CF. Type 2 Diabetes Mellitus. Williams Textbook of Endocrinology 2016. [DOI: 10.1016/b978-0-323-29738-7.00031-9] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
170 Garg A. Lipodystrophies. Genetic Diagnosis of Endocrine Disorders 2016. [DOI: 10.1016/b978-0-12-800892-8.00023-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
171 Pandit VS, Inamadar AC, Palit A. A Case With Lipodystrophy, Acanthosis Nigricans and Insulin Resistance. J Skin Stem Cell 2015;2. [DOI: 10.17795/jssc33522] [Reference Citation Analysis]
172 Brown GT, Kleiner DE. Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Metabolism 2016;65:1080-6. [PMID: 26775559 DOI: 10.1016/j.metabol.2015.11.008] [Cited by in Crossref: 141] [Cited by in F6Publishing: 150] [Article Influence: 17.6] [Reference Citation Analysis]
173 Satapathy SK, Kuwajima V, Nadelson J, Atiq O, Sanyal AJ. Drug-induced fatty liver disease: An overview of pathogenesis and management. Ann Hepatol 2015;14:789-806. [PMID: 26436351 DOI: 10.5604/16652681.1171749] [Cited by in Crossref: 62] [Cited by in F6Publishing: 62] [Article Influence: 7.8] [Reference Citation Analysis]
174 Meehan CA, Cochran E, Kassai A, Brown RJ, Gorden P. Metreleptin for injection to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy. Expert Rev Clin Pharmacol 2016;9:59-68. [PMID: 26465174 DOI: 10.1586/17512433.2016.1096772] [Cited by in Crossref: 38] [Cited by in F6Publishing: 43] [Article Influence: 4.8] [Reference Citation Analysis]
175 Toneatto J, Charó NL, Galigniana NM, Piwien-Pilipuk G. Adipogenesis is under surveillance of Hsp90 and the high molecular weight Immunophilin FKBP51. Adipocyte 2015;4:239-47. [PMID: 26451279 DOI: 10.1080/21623945.2015.1049401] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
176 Grundy SM. Adipose tissue and metabolic syndrome: too much, too little or neither. Eur J Clin Invest 2015;45:1209-17. [PMID: 26291691 DOI: 10.1111/eci.12519] [Cited by in Crossref: 106] [Cited by in F6Publishing: 112] [Article Influence: 13.3] [Reference Citation Analysis]
177 Bande-fernández JJ, García-castro R, Sánchez-alvarez JE, Rodríguez-suárez C, Coronel-aguilar D, Hidalgo C, Istanbuli B, Merino-bueno C, del Rio-garcía L. Berardinelli-Seip syndrome in peritoneal dialysis. Nefrología (English Edition) 2015;35:493-496. [DOI: 10.1016/j.nefroe.2015.11.005] [Reference Citation Analysis]
178 Patni N, Garg A. Congenital generalized lipodystrophies--new insights into metabolic dysfunction. Nat Rev Endocrinol 2015;11:522-34. [PMID: 26239609 DOI: 10.1038/nrendo.2015.123] [Cited by in Crossref: 148] [Cited by in F6Publishing: 156] [Article Influence: 18.5] [Reference Citation Analysis]
179 Haghighi A, Kavehmanesh Z, Haghighi A, Salehzadeh F, Santos-Simarro F, Van Maldergem L, Cimbalistiene L, Collins F, Chopra M, Al-Sinani S, Dastmalchian S, de Silva DC, Bakhti H, Garg A, Hilbert P. Congenital generalized lipodystrophy: identification of novel variants and expansion of clinical spectrum. Clin Genet 2016;89:434-41. [PMID: 26072926 DOI: 10.1111/cge.12623] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
180 Hu YJ, Belaghzal H, Hsiao WY, Qi J, Bradner JE, Guertin DA, Sif S, Imbalzano AN. Transcriptional and post-transcriptional control of adipocyte differentiation by Jumonji domain-containing protein 6. Nucleic Acids Res 2015;43:7790-804. [PMID: 26117538 DOI: 10.1093/nar/gkv645] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
181 Sorkina EL, Kalashnikova MF, Melnichenko GA, Tyulpakov AN. [Familial partial lipodystrophy (Dunnigan syndrome) due to LMNA gene mutation: The first description of its clinical case in Russia]. Ter Arkh 2015;87:83-7. [PMID: 26027246 DOI: 10.17116/terarkh201587383-87] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
182 Marangoni RG, Korman BD, Wei J, Wood TA, Graham LV, Whitfield ML, Scherer PE, Tourtellotte WG, Varga J. Myofibroblasts in murine cutaneous fibrosis originate from adiponectin-positive intradermal progenitors. Arthritis Rheumatol. 2015;67:1062-1073. [PMID: 25504959 DOI: 10.1002/art.38990] [Cited by in Crossref: 204] [Cited by in F6Publishing: 214] [Article Influence: 25.5] [Reference Citation Analysis]
183 Prieur X, Le May C, Magré J, Cariou B. Congenital lipodystrophies and dyslipidemias. Curr Atheroscler Rep 2014;16:437. [PMID: 25047893 DOI: 10.1007/s11883-014-0437-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
184 Brown RJ, Chan JL, Jaffe ES, Cochran E, DePaoli AM, Gautier JF, Goujard C, Vigouroux C, Gorden P. Lymphoma in acquired generalized lipodystrophy. Leuk Lymphoma 2016;57:45-50. [PMID: 25864863 DOI: 10.3109/10428194.2015.1040015] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
185 Belo SP, Magalhães ÂC, Freitas P, Carvalho DM. Familial partial lipodystrophy, Dunnigan variety - challenges for patient care during pregnancy: a case report. BMC Res Notes 2015;8:140. [PMID: 25885670 DOI: 10.1186/s13104-015-1065-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
186 Langhi C, Baldán Á. CIDEC/FSP27 is regulated by peroxisome proliferator-activated receptor alpha and plays a critical role in fasting- and diet-induced hepatosteatosis. Hepatology 2015;61:1227-38. [PMID: 25418138 DOI: 10.1002/hep.27607] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 6.8] [Reference Citation Analysis]
187 Shawky RM, Gamal R, Seifeldin NS. Berardinelli–Seip syndrome type 2 – An Egyptian child. Egyptian Journal of Medical Human Genetics 2015;16:189-193. [DOI: 10.1016/j.ejmhg.2014.08.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
188 Jalalzadeh M, Mousavinasab N, Soloki M, Miri R, Ghadiani MH, Hadizadeh M. Association between metabolic syndrome and coronary heart disease in patients on hemodialysis. Nephrourol Mon 2015;7:e25560. [PMID: 25738129 DOI: 10.5812/numonthly.25560] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
189 Guillín-amarelle C, Sánchez-iglesias S, Araújo-vilar D. Uncommon lipodystrophic syndromes. Medicina Clínica (English Edition) 2015;144:80-87. [DOI: 10.1016/j.medcle.2014.02.006] [Reference Citation Analysis]
190 Grunberger G, Myneni A. Syndromes of Extreme Insulin Resistance. Principles of Diabetes Mellitus 2015. [DOI: 10.1007/978-3-319-20797-1_17-1] [Reference Citation Analysis]
191 Asha HS, Chapla A, Shetty S, Thomas N. Next-Generation Sequencing-Based Genetic Testing For Familial Partial Lipodystrophy. AACE Clinical Case Reports 2015;1:e28-31. [DOI: 10.4158/ep14346.cr] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
192 Garg A. Lipodystrophies and Dyslipidemias. Dyslipidemias 2015. [DOI: 10.1007/978-1-60761-424-1_16] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
193 Cartwright BR, Binns DD, Hilton CL, Han S, Gao Q, Goodman JM. Seipin performs dissectible functions in promoting lipid droplet biogenesis and regulating droplet morphology. Mol Biol Cell 2015;26:726-39. [PMID: 25540432 DOI: 10.1091/mbc.E14-08-1303] [Cited by in Crossref: 106] [Cited by in F6Publishing: 112] [Article Influence: 11.8] [Reference Citation Analysis]
194 Rao TS, Chennamsetty K. Berardinelli-Seip congenital lipodystrophy in two siblings. Indian Dermatol Online J 2014;5:S20-2. [PMID: 25506557 DOI: 10.4103/2229-5178.144511] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
195 Lewandowicz E, Zieliński T, Iljin A, Fijałkowska M, Kasielska-Trojan A, Antoszewski B. Surgical treatment of skin lesions in lupus erythematosus. Postepy Dermatol Alergol 2014;31:405-9. [PMID: 25610357 DOI: 10.5114/pdia.2014.40931] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
196 Araujo-Vilar D, Sánchez-Iglesias S, Guillín-Amarelle C, Castro A, Lage M, Pazos M, Rial JM, Blasco J, Guillén-Navarro E, Domingo-Jiménez R, del Campo MR, González-Méndez B, Casanueva FF. Recombinant human leptin treatment in genetic lipodystrophic syndromes: the long-term Spanish experience. Endocrine 2015;49:139-47. [PMID: 25367549 DOI: 10.1007/s12020-014-0450-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
197 Wee K, Yang W, Sugii S, Han W. Towards a mechanistic understanding of lipodystrophy and seipin functions. Biosci Rep 2014;34:e00141. [PMID: 25195639 DOI: 10.1042/BSR20140114] [Cited by in Crossref: 16] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
198 Machado PV, Daxbacher EL, Obadia DL, Cunha EF, Alves Mde F, Mann D. Do you know this syndrome? Berardinelli-Seip syndrome. An Bras Dermatol 2013;88:1011-3. [PMID: 24474121 DOI: 10.1590/abd1806-4841.20132178] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
199 Greaves P, Chouinard L, Ernst H, Mecklenburg L, Pruimboom-Brees IM, Rinke M, Rittinghausen S, Thibault S, Von Erichsen J, Yoshida T. Proliferative and non-proliferative lesions of the rat and mouse soft tissue, skeletal muscle and mesothelium. J Toxicol Pathol 2013;26:1S-26S. [PMID: 25035576 DOI: 10.1293/tox.26.1S] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 5.2] [Reference Citation Analysis]
200 Freitas P, Carvalho D, Santos AC, Madureira AJ, Martinez E, Pereira J, Sarmento A, Medina JL. Adipokines, hormones related to body composition, and insulin resistance in HIV fat redistribution syndrome. BMC Infect Dis 2014;14:347. [PMID: 24958357 DOI: 10.1186/1471-2334-14-347] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
201 Vatier C, Bidault G, Briand N, Guénantin AC, Teyssières L, Lascols O, Capeau J, Vigouroux C. What the genetics of lipodystrophy can teach us about insulin resistance and diabetes. Curr Diab Rep 2013;13:757-67. [PMID: 24026869 DOI: 10.1007/s11892-013-0431-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
202 Munteanu MA, Mircea PA. From NAFLD to Cardiovascular Disease. Is it (Still) the Metabolic Syndrome? Clujul Med 2014;87:80-6. [PMID: 26528002 DOI: 10.15386/cjmed-277] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
203 O’Neill SM, Hinkle C, Chen SJ, Sandhu A, Hovhannisyan R, Stephan S, Lagor WR, Ahima RS, Johnston JC, Reilly MP. Targeting adipose tissue via systemic gene therapy. Gene Ther. 2014;21:653-661. [PMID: 24830434 DOI: 10.1038/gt.2014.38] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
204 Simsek-Kiper PO, Roach E, Utine GE, Boduroglu K. Barraquer-Simons syndrome: a rare clinical entity. Am J Med Genet A 2014;164A:1756-60. [PMID: 24788242 DOI: 10.1002/ajmg.a.36491] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
205 Jiang M, Gao M, Wu C, He H, Guo X, Zhou Z, Yang H, Xiao X, Liu G, Sha J. Lack of testicular seipin causes teratozoospermia syndrome in men. Proc Natl Acad Sci U S A 2014;111:7054-9. [PMID: 24778225 DOI: 10.1073/pnas.1324025111] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 5.7] [Reference Citation Analysis]
206 Steen ER, De Baerdemaeker LEC, Van Limmen J, Wouters P. Some Pharmacokinetics of Sevoflurane in a Child with Severe Lipodystrophy. A & A Case Reports 2014;2:61-64. [DOI: 10.1097/acc.0b013e3182a706f6] [Reference Citation Analysis]
207 Liu J, Coady S, Carr JJ, Hoffmann U, Taylor HA, Fox CS. Differential associations of abdominal visceral, subcutaneous adipose tissue with cardiometabolic risk factors between African and European Americans. Obesity (Silver Spring) 2014;22:811-8. [PMID: 23408700 DOI: 10.1002/oby.20307] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
208 Cortés VA, Smalley SV, Goldenberg D, Lagos CF, Hodgson MI, Santos JL. Divergent metabolic phenotype between two sisters with congenital generalized lipodystrophy due to double AGPAT2 homozygous mutations. a clinical, genetic and in silico study. PLoS One 2014;9:e87173. [PMID: 24498038 DOI: 10.1371/journal.pone.0087173] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
209 Nakayama H, Ikeya S, Okamoto D, Komazawa D, Watanabe T, Itou H, Tosa M, Dairaku N, Ikeda T, Takahashi S, Hiwatashi N. Pioglitazone therapy could improve histology of a lean patient with advanced nonalcoholic steatohepatitis. A case report. Kanzo 2014;55:57-65. [DOI: 10.2957/kanzo.55.57] [Reference Citation Analysis]
210 Weiss R, Lustig RH. Obesity, metabolic syndrome, and disorders of energy balance. Pediatric Endocrinology 2014. [DOI: 10.1016/b978-1-4557-4858-7.00031-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
211 Dragović G, Malović D, Jevtović Đ. Metabolic syndrome and combined highly active antiretroviral therapy. Medicinska istraživanja 2014;48:24-31. [DOI: 10.5937/medist1401024d] [Reference Citation Analysis]
212 Araújo RS, Ramos ADPS, Borges MDAS. Bezafibrato em lactente portador de lipodistrofia generalizada congênita e hipertrigliceridemia grave. Arq Bras Endocrinol Metab 2013;57:653-658. [DOI: 10.1590/s0004-27302013000800012] [Reference Citation Analysis]
213 Adachi M, Asakura Y, Muroya K, Goto H, Kigasawa H. Abnormal adipose tissue distribution with unfavorable metabolic profile in five children following hematopoietic stem cell transplantation: a new etiology for acquired partial lipodystrophy. Clin Pediatr Endocrinol 2013;22:53-64. [PMID: 24170962 DOI: 10.1292/cpe.22.53] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
214 Adachi M, Asakura Y, Muroya K, Goto H, Kigasawa H. Abnormal adipose tissue distribution with unfavorable metabolic profile in five children following hematopoietic stem cell transplantation: a new etiology for acquired partial lipodystrophy. Clin Pediatr Endocrinol 2013;22:53-64. [PMID: 24170962 DOI: 10.1292/cpe.22.53] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
215 Nolis T. Exploring the pathophysiology behind the more common genetic and acquired lipodystrophies. J Hum Genet 2014;59:16-23. [PMID: 24152769 DOI: 10.1038/jhg.2013.107] [Cited by in Crossref: 54] [Cited by in F6Publishing: 58] [Article Influence: 5.4] [Reference Citation Analysis]
216 Hallock GG. Precautions in using a perforator free flap to treat mandibuloacral dysplasia--a case report. Microsurgery 2014;34:311-3. [PMID: 24123119 DOI: 10.1002/micr.22189] [Reference Citation Analysis]
217 Pretel M, Navedo M, Marqués L, Aguado L. Dermatomiositis del adulto asociada a lipodistrofia. Actas Dermo-Sifiliográficas 2013;104:724-725. [DOI: 10.1016/j.ad.2012.07.021] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
218 Srisawasdi P, Suwalak T, Sukasem C, Chittamma A, Pocathikorn A, Vanavanan S, Puangpetch A, Santon S, Chantratita W, Kiertiburanakul S, Kroll MH. Small-dense LDL cholesterol/large-buoyant LDL cholesterol ratio as an excellent marker for indicating lipodystrophy in HIV-infected patients. Am J Clin Pathol 2013;140:506-15. [PMID: 24045547 DOI: 10.1309/AJCPE5I3KELTBXEJ] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
219 Challis BG, Semple RK. Genetic Disorders of Insulin Action: Far More than Diabetes. Curr Obes Rep 2013;2:293-300. [DOI: 10.1007/s13679-013-0075-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
220 Parker VE, Semple RK. Genetics in endocrinology: genetic forms of severe insulin resistance: what endocrinologists should know. Eur J Endocrinol. 2013;169:R71-R80. [PMID: 23857978 DOI: 10.1530/eje-13-0327] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 3.2] [Reference Citation Analysis]
221 Handelsman Y, Oral EA, Bloomgarden ZT, Brown RJ, Chan JL, Einhorn D, Garber AJ, Garg A, Garvey WT, Grunberger G, Henry RR, Lavin N, Tapiador CD, Weyer C; American Association of Clinical Endocrinologists. The clinical approach to the detection of lipodystrophy - an AACE consensus statement. Endocr Pract 2013;19:107-16. [PMID: 23435042 DOI: 10.4158/endp.19.1.v767575m65p5mr06] [Cited by in Crossref: 59] [Cited by in F6Publishing: 69] [Article Influence: 5.9] [Reference Citation Analysis]
222 Chudasama KK, Winnay J, Johansson S, Claudi T, König R, Haldorsen I, Johansson B, Woo JR, Aarskog D, Sagen JV, Kahn CR, Molven A, Njølstad PR. SHORT syndrome with partial lipodystrophy due to impaired phosphatidylinositol 3 kinase signaling. Am J Hum Genet 2013;93:150-7. [PMID: 23810379 DOI: 10.1016/j.ajhg.2013.05.023] [Cited by in Crossref: 100] [Cited by in F6Publishing: 102] [Article Influence: 10.0] [Reference Citation Analysis]
223 Kohlwein SD, Veenhuis M, van der Klei IJ. Lipid droplets and peroxisomes: key players in cellular lipid homeostasis or a matter of fat--store 'em up or burn 'em down. Genetics 2013;193:1-50. [PMID: 23275493 DOI: 10.1534/genetics.112.143362] [Cited by in Crossref: 163] [Cited by in F6Publishing: 168] [Article Influence: 16.3] [Reference Citation Analysis]
224 Krahmer N, Farese RV Jr, Walther TC. Balancing the fat: lipid droplets and human disease. EMBO Mol Med 2013;5:973-83. [PMID: 23740690 DOI: 10.1002/emmm.201100671] [Cited by in Crossref: 296] [Cited by in F6Publishing: 309] [Article Influence: 29.6] [Reference Citation Analysis]
225 Sanchez-Gurmaches J, Guertin DA. Adipocyte lineages: tracing back the origins of fat. Biochim Biophys Acta. 2014;1842:340-351. [PMID: 23747579 DOI: 10.1016/j.bbadis.2013.05.027] [Cited by in Crossref: 157] [Cited by in F6Publishing: 143] [Article Influence: 15.7] [Reference Citation Analysis]
226 McPherron AC, Guo T, Bond ND, Gavrilova O. Increasing muscle mass to improve metabolism. Adipocyte 2013;2:92-8. [PMID: 23805405 DOI: 10.4161/adip.22500] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
227 Weiss R, Bremer AA, Lustig RH. What is metabolic syndrome, and why are children getting it? Ann N Y Acad Sci 2013;1281:123-40. [PMID: 23356701 DOI: 10.1111/nyas.12030] [Cited by in Crossref: 163] [Cited by in F6Publishing: 178] [Article Influence: 16.3] [Reference Citation Analysis]
228 Ferraria N, Pedrosa C, Amaral D, Lopes L. Berardinelli-Seip syndrome: highlight of treatment challenge. BMJ Case Rep 2013;2013:bcr2012007734. [PMID: 23362058 DOI: 10.1136/bcr-2012-007734] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
229 Pahuja I, De P, Sharma N, Kulshreshtha B. Polycystic ovarian syndrome in patients with lipodystrophy: Report of 2 cases with review of literature. Indian J Endocrinol Metab 2012;16:1022-5. [PMID: 23226657 DOI: 10.4103/2230-8210.103031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
230 Lanktree MB, Joy TR, Hegele RA. The Metabolic Syndrome. Genomic and Personalized Medicine 2013. [DOI: 10.1016/b978-0-12-382227-7.00083-5] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
231 Kurban M, Christiano AM. Inherited Disorders of the Hair. Emery and Rimoin's Principles and Practice of Medical Genetics 2013. [DOI: 10.1016/b978-0-12-383834-6.00182-8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
232 Garg A. Genetic Lipodystrophies. Emery and Rimoin's Principles and Practice of Medical Genetics 2013. [DOI: 10.1016/b978-0-12-383834-6.00095-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
233 He Z, Zhu HH, Bauler TJ, Wang J, Ciaraldi T, Alderson N, Li S, Raquil MA, Ji K, Wang S, Shao J, Henry RR, King PD, Feng GS. Nonreceptor tyrosine phosphatase Shp2 promotes adipogenesis through inhibition of p38 MAP kinase. Proc Natl Acad Sci U S A 2013;110:E79-88. [PMID: 23236157 DOI: 10.1073/pnas.1213000110] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 3.5] [Reference Citation Analysis]
234 Zeve D, Seo J, Suh JM, Stenesen D, Tang W, Berglund ED, Wan Y, Williams LJ, Lim A, Martinez MJ, McKay RM, Millay DP, Olson EN, Graff JM. Wnt signaling activation in adipose progenitors promotes insulin-independent muscle glucose uptake. Cell Metab 2012;15:492-504. [PMID: 22482731 DOI: 10.1016/j.cmet.2012.03.010] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 5.1] [Reference Citation Analysis]
235 Gorden P, Zadeh ES, Cochran E, Brown RJ. Syndromic insulin resistance: models for the therapeutic basis of the metabolic syndrome and other targets of insulin resistance. Endocr Pract 2012;18:763-71. [PMID: 23047930 DOI: 10.4158/EP12139.RA] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
236 Monteiro LZ, Foss-Freitas MC, Júnior Montenegro RM, Foss MC. Body fat distribution in women with familial partial lipodystrophy caused by mutation in the lamin A/C gene. Indian J Endocrinol Metab 2012;16:136-8. [PMID: 22276265 DOI: 10.4103/2230-8210.91209] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
237 Valerio CM, Zajdenverg L, de Oliveira JE, Mory PB, Moyses RS, Godoy-Matos AF. Body composition study by dual-energy x-ray absorptiometry in familial partial lipodystrophy: finding new tools for an objective evaluation. Diabetol Metab Syndr 2012;4:40. [PMID: 22938045 DOI: 10.1186/1758-5996-4-40] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
238 Sansbury BE, Cummins TD, Tang Y, Hellmann J, Holden CR, Harbeson MA, Chen Y, Patel RP, Spite M, Bhatnagar A, Hill BG. Overexpression of endothelial nitric oxide synthase prevents diet-induced obesity and regulates adipocyte phenotype. Circ Res 2012;111:1176-89. [PMID: 22896587 DOI: 10.1161/CIRCRESAHA.112.266395] [Cited by in Crossref: 103] [Cited by in F6Publishing: 106] [Article Influence: 9.4] [Reference Citation Analysis]
239 Rubio Cabezas O, Argente J. [Diabetes mellitus: clinical presentation and differential diagnosis of hyperglycemia in childhood and adolescence]. An Pediatr (Barc) 2012;77:344.e1-344.e16. [PMID: 22857943 DOI: 10.1016/j.anpedi.2012.06.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
240 Haghighi A, Razzaghy-Azar M, Talea A, Sadeghian M, Ellard S, Haghighi A. Identification of a novel nonsense mutation and a missense substitution in the AGPAT2 gene causing congenital generalized lipodystrophy type 1. Eur J Med Genet 2012;55:620-4. [PMID: 22902344 DOI: 10.1016/j.ejmg.2012.07.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
241 Larrain S, Rinella ME. A myriad of pathways to NASH. Clin Liver Dis 2012;16:525-48. [PMID: 22824479 DOI: 10.1016/j.cld.2012.05.009] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 2.6] [Reference Citation Analysis]
242 Fardet L, Petersen I, Nazareth I. Risk of cardiovascular events in people prescribed glucocorticoids with iatrogenic Cushing's syndrome: cohort study. BMJ 2012;345:e4928. [PMID: 22846415 DOI: 10.1136/bmj.e4928] [Cited by in Crossref: 60] [Cited by in F6Publishing: 67] [Article Influence: 5.5] [Reference Citation Analysis]
243 Scherer T, Lindtner C, Zielinski E, O'Hare J, Filatova N, Buettner C. Short term voluntary overfeeding disrupts brain insulin control of adipose tissue lipolysis. J Biol Chem 2012;287:33061-9. [PMID: 22810223 DOI: 10.1074/jbc.M111.307348] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 4.7] [Reference Citation Analysis]
244 Campeau PM, Astapova O, Martins R, Bergeron J, Couture P, Hegele RA, Leff T, Gagné C. Clinical and molecular characterization of a severe form of partial lipodystrophy expanding the phenotype of PPARγ deficiency. J Lipid Res 2012;53:1968-78. [PMID: 22750678 DOI: 10.1194/jlr.P025437] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
245 Hebebrand J, Albayrak Ö. Leptin treatment of patients with anorexia nervosa? The urgent need for initiation of clinical studies. Eur Child Adolesc Psychiatry. 2012;21:63-66. [PMID: 22290117 DOI: 10.1007/s00787-012-0243-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
246 Maraldi NM. Resistenza insulinica e malattie rare: le lipodistrofie monogeniche. L'Endocrinologo 2012;13:122-126. [DOI: 10.1007/bf03345964] [Reference Citation Analysis]
247 Razzaque MS. The role of Klotho in energy metabolism. Nat Rev Endocrinol. 2012;8:579-587. [PMID: 22641000 DOI: 10.1038/nrendo.2012.75] [Cited by in Crossref: 56] [Cited by in F6Publishing: 63] [Article Influence: 5.1] [Reference Citation Analysis]
248 Chan JL, Lutz K, Cochran E, Huang W, Peters Y, Weyer C, Gorden P. Clinical effects of long-term metreleptin treatment in patients with lipodystrophy. Endocr Pract 2011;17:922-32. [PMID: 22068254 DOI: 10.4158/EP11229.OR] [Cited by in Crossref: 101] [Cited by in F6Publishing: 113] [Article Influence: 9.2] [Reference Citation Analysis]
249 Guo T, Bond ND, Jou W, Gavrilova O, Portas J, McPherron AC. Myostatin inhibition prevents diabetes and hyperphagia in a mouse model of lipodystrophy. Diabetes. 2012;61:2414-2423. [PMID: 22596054 DOI: 10.2337/db11-0915] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 4.5] [Reference Citation Analysis]
250 Hardie DG. Organismal carbohydrate and lipid homeostasis. Cold Spring Harb Perspect Biol 2012;4:a006031. [PMID: 22550228 DOI: 10.1101/cshperspect.a006031] [Cited by in Crossref: 41] [Cited by in F6Publishing: 48] [Article Influence: 3.7] [Reference Citation Analysis]
251 Yang L, Ding Y, Chen Y, Zhang S, Huo C, Wang Y, Yu J, Zhang P, Na H, Zhang H, Ma Y, Liu P. The proteomics of lipid droplets: structure, dynamics, and functions of the organelle conserved from bacteria to humans. J Lipid Res 2012;53:1245-53. [PMID: 22534641 DOI: 10.1194/jlr.R024117] [Cited by in Crossref: 153] [Cited by in F6Publishing: 155] [Article Influence: 13.9] [Reference Citation Analysis]
252 Cartwright BR, Goodman JM. Seipin: from human disease to molecular mechanism. J Lipid Res 2012;53:1042-55. [PMID: 22474068 DOI: 10.1194/jlr.R023754] [Cited by in Crossref: 91] [Cited by in F6Publishing: 101] [Article Influence: 8.3] [Reference Citation Analysis]
253 Maguire M, Lungu A, Gorden P, Cochran E, Stratton P. Pregnancy in a woman with congenital generalized lipodystrophy: leptin's vital role in reproduction. Obstet Gynecol 2012;119:452-5. [PMID: 22270436 DOI: 10.1097/AOG.0b013e31822cecf7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
254 Thompson RJ, Portmann BC, Roberts EA. Genetic and metabolic liver disease. MacSween's Pathology of the Liver 2012. [DOI: 10.1016/b978-0-7020-3398-8.00004-0] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
255 Guaraldi G, Bonucci PL, De Fazio D. Comparison of Three Different Methods for Correction of HIV-Associated Facial Lipodystrophy. Advanced Surgical Facial Rejuvenation 2012. [DOI: 10.1007/978-3-642-17838-2_64] [Reference Citation Analysis]
256 Rose C. Erkrankungen des Fettgewebes. Braun-Falco’s Dermatologie, Venerologie und Allergologie 2012. [DOI: 10.1007/978-3-642-24163-5_78] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
257 Greaves P. Integumentary System. Histopathology of Preclinical Toxicity Studies 2012. [DOI: 10.1016/b978-0-444-53856-7.00002-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
258 . Congenital Generalized Lipodystrophy. Atlas of Genetic Diagnosis and Counseling 2012. [DOI: 10.1007/978-1-4614-1037-9_51] [Reference Citation Analysis]
259 Singhania R, Kotler DP. Lipodystrophy in HIV patients: its challenges and management approaches. HIV AIDS (Auckl) 2011;3:135-43. [PMID: 22267946 DOI: 10.2147/HIV.S14562] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.1] [Reference Citation Analysis]
260 Simha V, Subramanyam L, Szczepaniak L, Quittner C, Adams-Huet B, Snell P, Garg A. Comparison of efficacy and safety of leptin replacement therapy in moderately and severely hypoleptinemic patients with familial partial lipodystrophy of the Dunnigan variety. J Clin Endocrinol Metab 2012;97:785-92. [PMID: 22170723 DOI: 10.1210/jc.2011-2229] [Cited by in Crossref: 63] [Cited by in F6Publishing: 71] [Article Influence: 5.3] [Reference Citation Analysis]
261 Scherer T, Buettner C. Yin and Yang of hypothalamic insulin and leptin signaling in regulating white adipose tissue metabolism. Rev Endocr Metab Disord 2011;12:235-43. [PMID: 21713385 DOI: 10.1007/s11154-011-9190-4] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 3.8] [Reference Citation Analysis]
262 Caldwell SH, Argo CK, Al‐osaimi AMS. Nonalcoholic Fatty Liver Disease. Schiff's Diseases of the Liver 2011. [DOI: 10.1002/9781119950509.ch32] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
263 Indumathi CK, Lewin S, Ayyar V. Berardinelli Seip syndrome with insulin-resistant diabetes mellitus and stroke in an infant. Indian J Endocrinol Metab 2011;15:S62-4. [PMID: 21847459 DOI: 10.4103/2230-8210.83054] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
264 Jeninga EH, de Vroede M, Hamers N, Breur JM, Verhoeven-Duif NM, Berger R, Kalkhoven E. A Patient with Congenital Generalized Lipodystrophy Due To a Novel Mutation in BSCL2: Indications for Secondary Mitochondrial Dysfunction. JIMD Rep 2012;4:47-54. [PMID: 23430896 DOI: 10.1007/8904_2011_86] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
265 Foster MC, Yang Q, Hwang SJ, Hoffmann U, Fox CS. Heritability and genome-wide association analysis of renal sinus fat accumulation in the Framingham Heart Study. BMC Med Genet 2011;12:148. [PMID: 22044751 DOI: 10.1186/1471-2350-12-148] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
266 Freitas P, Carvalho D, Souto S, Santos AC, Xerinda S, Marques R, Martinez E, Sarmento A, Medina JL. Impact of Lipodystrophy on the prevalence and components of metabolic syndrome in HIV-infected patients. BMC Infect Dis 2011;11:246. [PMID: 21933422 DOI: 10.1186/1471-2334-11-246] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 2.9] [Reference Citation Analysis]
267 Pelosini C, Martinelli S, Bagattini B, Pucci E, Fierabracci P, Scartabelli G, Salvetti G, Vitti P, Maffei M, Pinchera A, Santini F. Description of an AGPAT2 pathologic allelic variant in a 54-year-old Caucasian woman with Berardinelli-Seip syndrome. Acta Diabetol 2011;48:243-6. [PMID: 21744063 DOI: 10.1007/s00592-011-0308-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
268 Agarwal AK, Sukumaran S, Cortés VA, Tunison K, Mizrachi D, Sankella S, Gerard RD, Horton JD, Garg A. Human 1-acylglycerol-3-phosphate O-acyltransferase isoforms 1 and 2: biochemical characterization and inability to rescue hepatic steatosis in Agpat2(-/-) gene lipodystrophic mice. J Biol Chem 2011;286:37676-91. [PMID: 21873652 DOI: 10.1074/jbc.M111.250449] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 5.1] [Reference Citation Analysis]
269 Garg A. Clinical review#: Lipodystrophies: genetic and acquired body fat disorders. J Clin Endocrinol Metab. 2011;96:3313-3325. [PMID: 21865368 DOI: 10.1210/jc.2011-1159] [Cited by in Crossref: 341] [Cited by in F6Publishing: 362] [Article Influence: 28.4] [Reference Citation Analysis]
270 van Wijk JP, Cabezas MC. Hypertriglyceridemia, Metabolic Syndrome, and Cardiovascular Disease in HIV-Infected Patients: Effects of Antiretroviral Therapy and Adipose Tissue Distribution. Int J Vasc Med 2012;2012:201027. [PMID: 21876813 DOI: 10.1155/2012/201027] [Cited by in Crossref: 12] [Cited by in F6Publishing: 25] [Article Influence: 1.0] [Reference Citation Analysis]
271 Peinado JR, Quirós PM, Pulido MR, Mariño G, Martínez-Chantar ML, Vázquez-Martínez R, Freije JM, López-Otín C, Malagón MM. Proteomic profiling of adipose tissue from Zmpste24-/- mice, a model of lipodystrophy and premature aging, reveals major changes in mitochondrial function and vimentin processing. Mol Cell Proteomics 2011;10:M111.008094. [PMID: 21828285 DOI: 10.1074/mcp.M111.008094] [Cited by in Crossref: 46] [Cited by in F6Publishing: 51] [Article Influence: 3.8] [Reference Citation Analysis]
272 Anand SS, Tarnopolsky MA, Rashid S, Schulze KM, Desai D, Mente A, Rao S, Yusuf S, Gerstein HC, Sharma AM. Adipocyte hypertrophy, fatty liver and metabolic risk factors in South Asians: the Molecular Study of Health and Risk in Ethnic Groups (mol-SHARE). PLoS One 2011;6:e22112. [PMID: 21829446 DOI: 10.1371/journal.pone.0022112] [Cited by in Crossref: 105] [Cited by in F6Publishing: 109] [Article Influence: 8.8] [Reference Citation Analysis]
273 Bedimo R. Growth hormone and tesamorelin in the management of HIV-associated lipodystrophy. HIV AIDS (Auckl) 2011;3:69-79. [PMID: 22096409 DOI: 10.2147/HIV.S14561] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
274 Sam S, Mazzone T. Reducing the risk of macrovascular complications of diabetes: focus on visceral fat. Diabetes Management 2011;1:439-449. [DOI: 10.2217/dmt.11.22] [Reference Citation Analysis]
275 Massella M, Ivanovic J, Bellagamba R, De Vita R, Fracasso L, Tozzi V, Fragola V, Rizzica M, Narciso P. Cost of surgical intervention for reconstructive therapy of HIV-associated facial lipoatrophy. Patient Prefer Adherence 2011;5:223-8. [PMID: 21660104 DOI: 10.2147/PPA.S16819] [Reference Citation Analysis]
276 Mudhasani R, Puri V, Hoover K, Czech MP, Imbalzano AN, Jones SN. Dicer is required for the formation of white but not brown adipose tissue. J Cell Physiol 2011;226:1399-406. [PMID: 20945399 DOI: 10.1002/jcp.22475] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 4.6] [Reference Citation Analysis]
277 Herrera BM, Keildson S, Lindgren CM. Genetics and epigenetics of obesity. Maturitas. 2011;69:41-49. [PMID: 21466928 DOI: 10.1016/j.maturitas.2011.02.018] [Cited by in Crossref: 188] [Cited by in F6Publishing: 137] [Article Influence: 15.7] [Reference Citation Analysis]
278 . References. A Guide to Obesity and the Metabolic Syndrome 2011. [DOI: 10.1201/b10790-15] [Reference Citation Analysis]
279 Gandotra S, Le Dour C, Bottomley W, Cervera P, Giral P, Reznik Y, Charpentier G, Auclair M, Delépine M, Barroso I, Semple RK, Lathrop M, Lascols O, Capeau J, O'Rahilly S, Magré J, Savage DB, Vigouroux C. Perilipin deficiency and autosomal dominant partial lipodystrophy. N Engl J Med 2011;364:740-8. [PMID: 21345103 DOI: 10.1056/NEJMoa1007487] [Cited by in Crossref: 210] [Cited by in F6Publishing: 216] [Article Influence: 17.5] [Reference Citation Analysis]
280 Ahmad Z, Zackai E, Medne L, Garg A. Early onset mandibuloacral dysplasia due to compound heterozygous mutations in ZMPSTE24. Am J Med Genet A 2010;152A:2703-10. [PMID: 20814950 DOI: 10.1002/ajmg.a.33664] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 3.1] [Reference Citation Analysis]
281 Huang-Doran I, Bicknell LS, Finucane FM, Rocha N, Porter KM, Tung YC, Szekeres F, Krook A, Nolan JJ, O'Driscoll M, Bober M, O'Rahilly S, Jackson AP, Semple RK; Majewski Osteodysplastic Primordial Dwarfism Study Group. Genetic defects in human pericentrin are associated with severe insulin resistance and diabetes. Diabetes 2011;60:925-35. [PMID: 21270239 DOI: 10.2337/db10-1334] [Cited by in Crossref: 43] [Cited by in F6Publishing: 48] [Article Influence: 3.6] [Reference Citation Analysis]
282 Lindgren C. A Genome-wide Association Case Study on Obesity. Analysis of Complex Disease Association Studies 2011. [DOI: 10.1016/b978-0-12-375142-3.10018-5] [Reference Citation Analysis]
283 Binns D, Lee S, Hilton CL, Jiang QX, Goodman JM. Seipin is a discrete homooligomer. Biochemistry 2010;49:10747-55. [PMID: 21062080 DOI: 10.1021/bi1013003] [Cited by in Crossref: 98] [Cited by in F6Publishing: 102] [Article Influence: 7.5] [Reference Citation Analysis]
284 Fiorenza CG, Chou SH, Mantzoros CS. Lipodystrophy: pathophysiology and advances in treatment. Nat Rev Endocrinol. 2011;7:137-150. [PMID: 21079616 DOI: 10.1038/nrendo.2010.199] [Cited by in Crossref: 166] [Cited by in F6Publishing: 176] [Article Influence: 12.8] [Reference Citation Analysis]
285 Roth T, Nair S, Kumar A. Monogenic diabetes secondary to congenital lipodystrophy in a 14-year-old Yemeni girl. J Clin Res Pediatr Endocrinol 2010;2:176-9. [PMID: 21274320 DOI: 10.4274/jcrpe.v2i4.176] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
286 Foth D, Rahimi G. Treatment of Hirsutism in a Woman With Familial Partial Lipodystrophy of Dunnigan Type. The Endocrinologist 2010;20:290-292. [DOI: 10.1097/ten.0b013e3181fd0409] [Reference Citation Analysis]
287 Rocchietti March M, Proietta M, Trappolini M, Pisani D, Grimaldi M, Pranteda G, Aliberti G. Lipodystrophy in an HIV-infected Patient. The Endocrinologist 2010;20:293-295. [DOI: 10.1097/ten.0b013e318204e16c] [Reference Citation Analysis]
288 Camacho D, Pielasinski U, Revelles JM, González M, Haro R, Martín L, Santonja C, Requena L. Diffuse lower limb lipoatrophy. J Cutan Pathol 2011;38:270-4. [PMID: 20973808 DOI: 10.1111/j.1600-0560.2010.01639.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
289 Heid IM, Jackson AU, Randall JC, Winkler TW, Qi L, Steinthorsdottir V, Thorleifsson G, Zillikens MC, Speliotes EK, Mägi R, Workalemahu T, White CC, Bouatia-Naji N, Harris TB, Berndt SI, Ingelsson E, Willer CJ, Weedon MN, Luan J, Vedantam S, Esko T, Kilpeläinen TO, Kutalik Z, Li S, Monda KL, Dixon AL, Holmes CC, Kaplan LM, Liang L, Min JL, Moffatt MF, Molony C, Nicholson G, Schadt EE, Zondervan KT, Feitosa MF, Ferreira T, Lango Allen H, Weyant RJ, Wheeler E, Wood AR, Estrada K, Goddard ME, Lettre G, Mangino M, Nyholt DR, Purcell S, Smith AV, Visscher PM, Yang J, McCarroll SA, Nemesh J, Voight BF, Absher D, Amin N, Aspelund T, Coin L, Glazer NL, Hayward C, Heard-Costa NL, Hottenga JJ, Johansson A, Johnson T, Kaakinen M, Kapur K, Ketkar S, Knowles JW, Kraft P, Kraja AT, Lamina C, Leitzmann MF, McKnight B, Morris AP, Ong KK, Perry JR, Peters MJ, Polasek O, Prokopenko I, Rayner NW, Ripatti S, Rivadeneira F, Robertson NR, Sanna S, Sovio U, Surakka I, Teumer A, van Wingerden S, Vitart V, Zhao JH, Cavalcanti-Proença C, Chines PS, Fisher E, Kulzer JR, Lecoeur C, Narisu N, Sandholt C, Scott LJ, Silander K, Stark K, Tammesoo ML, Teslovich TM, Timpson NJ, Watanabe RM, Welch R, Chasman DI, Cooper MN, Jansson JO, Kettunen J, Lawrence RW, Pellikka N, Perola M, Vandenput L, Alavere H, Almgren P, Atwood LD, Bennett AJ, Biffar R, Bonnycastle LL, Bornstein SR, Buchanan TA, Campbell H, Day IN, Dei M, Dörr M, Elliott P, Erdos MR, Eriksson JG, Freimer NB, Fu M, Gaget S, Geus EJ, Gjesing AP, Grallert H, Grässler J, Groves CJ, Guiducci C, Hartikainen AL, Hassanali N, Havulinna AS, Herzig KH, Hicks AA, Hui J, Igl W, Jousilahti P, Jula A, Kajantie E, Kinnunen L, Kolcic I, Koskinen S, Kovacs P, Kroemer HK, Krzelj V, Kuusisto J, Kvaloy K, Laitinen J, Lantieri O, Lathrop GM, Lokki ML, Luben RN, Ludwig B, McArdle WL, McCarthy A, Morken MA, Nelis M, Neville MJ, Paré G, Parker AN, Peden JF, Pichler I, Pietiläinen KH, Platou CG, Pouta A, Ridderstråle M, Samani NJ, Saramies J, Sinisalo J, Smit JH, Strawbridge RJ, Stringham HM, Swift AJ, Teder-Laving M, Thomson B, Usala G, van Meurs JB, van Ommen GJ, Vatin V, Volpato CB, Wallaschofski H, Walters GB, Widen E, Wild SH, Willemsen G, Witte DR, Zgaga L, Zitting P, Beilby JP, James AL, Kähönen M, Lehtimäki T, Nieminen MS, Ohlsson C, Palmer LJ, Raitakari O, Ridker PM, Stumvoll M, Tönjes A, Viikari J, Balkau B, Ben-Shlomo Y, Bergman RN, Boeing H, Smith GD, Ebrahim S, Froguel P, Hansen T, Hengstenberg C, Hveem K, Isomaa B, Jørgensen T, Karpe F, Khaw KT, Laakso M, Lawlor DA, Marre M, Meitinger T, Metspalu A, Midthjell K, Pedersen O, Salomaa V, Schwarz PE, Tuomi T, Tuomilehto J, Valle TT, Wareham NJ, Arnold AM, Beckmann JS, Bergmann S, Boerwinkle E, Boomsma DI, Caulfield MJ, Collins FS, Eiriksdottir G, Gudnason V, Gyllensten U, Hamsten A, Hattersley AT, Hofman A, Hu FB, Illig T, Iribarren C, Jarvelin MR, Kao WH, Kaprio J, Launer LJ, Munroe PB, Oostra B, Penninx BW, Pramstaller PP, Psaty BM, Quertermous T, Rissanen A, Rudan I, Shuldiner AR, Soranzo N, Spector TD, Syvanen AC, Uda M, Uitterlinden A, Völzke H, Vollenweider P, Wilson JF, Witteman JC, Wright AF, Abecasis GR, Boehnke M, Borecki IB, Deloukas P, Frayling TM, Groop LC, Haritunians T, Hunter DJ, Kaplan RC, North KE, O'Connell JR, Peltonen L, Schlessinger D, Strachan DP, Hirschhorn JN, Assimes TL, Wichmann HE, Thorsteinsdottir U, van Duijn CM, Stefansson K, Cupples LA, Loos RJ, Barroso I, McCarthy MI, Fox CS, Mohlke KL, Lindgren CM; MAGIC. Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet 2010;42:949-60. [PMID: 20935629 DOI: 10.1038/ng.685] [Cited by in Crossref: 701] [Cited by in F6Publishing: 735] [Article Influence: 53.9] [Reference Citation Analysis]
290 . Other Types of Diabetes. Handbook of Diabetes 2010. [DOI: 10.1002/9781444391374.ch8] [Reference Citation Analysis]
291 Saha B, Lessel D, Hisama FM, Leistritz DF, Friedrich K, Martin GM, Kubisch C, Oshima J. A Novel LMNA Mutation Causes Altered Nuclear Morphology and Symptoms of Familial Partial Lipodystrophy (Dunnigan Variety) with Progeroid Features. Mol Syndromol 2010;1:127-32. [PMID: 21031082 DOI: 10.1159/000320166] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
292 Moreira RO, Zagury RL, Nascimento TS, Zagury L. Multidrug therapy in a patient with Rabson-Mendenhall syndrome. Diabetologia. 2010;53:2454-2455. [PMID: 20711714 DOI: 10.1007/s00125-010-1879-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
293 Chun TH, Inoue M, Morisaki H, Yamanaka I, Miyamoto Y, Okamura T, Sato-Kusubata K, Weiss SJ. Genetic link between obesity and MMP14-dependent adipogenic collagen turnover. Diabetes 2010;59:2484-94. [PMID: 20660624 DOI: 10.2337/db10-0073] [Cited by in Crossref: 70] [Cited by in F6Publishing: 73] [Article Influence: 5.4] [Reference Citation Analysis]
294 Samuel VT, Petersen KF, Shulman GI. Lipid-induced insulin resistance: unravelling the mechanism. Lancet. 2010;375:2267-2277. [PMID: 20609972 DOI: 10.1016/s0140-6736(10)60408-4] [Cited by in Crossref: 774] [Cited by in F6Publishing: 807] [Article Influence: 59.5] [Reference Citation Analysis]
295 Jones A, Hattersley AT. Monogenic Causes of Diabetes. Textbook of Diabetes 2010. [DOI: 10.1002/9781444324808.ch15] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
296 Capeau J, Magré J, Caron-Debarle M, Lagathu C, Antoine B, Béréziat VR, Lascols O, Bastard JP, Vigouroux C. Human lipodystrophies: genetic and acquired diseases of adipose tissue. Endocr Dev 2010;19:1-20. [PMID: 20551664 DOI: 10.1159/000316893] [Cited by in Crossref: 56] [Cited by in F6Publishing: 60] [Article Influence: 4.3] [Reference Citation Analysis]
297 Garg A, Hernandez MD, Sousa AB, Subramanyam L, Martínez de Villarreal L, dos Santos HG, Barboza O. An autosomal recessive syndrome of joint contractures, muscular atrophy, microcytic anemia, and panniculitis-associated lipodystrophy. J Clin Endocrinol Metab 2010;95:E58-63. [PMID: 20534754 DOI: 10.1210/jc.2010-0488] [Cited by in Crossref: 78] [Cited by in F6Publishing: 81] [Article Influence: 6.0] [Reference Citation Analysis]
298 Mcgibbon DH. Subcutaneous Fat. Rook's Textbook of Dermatology 2010. [DOI: 10.1002/9781444317633.ch46] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
299 Considine RV. Leptin Secretion and Action. Adipose Tissue in Health and Disease 2010. [DOI: 10.1002/9783527629527.ch10] [Reference Citation Analysis]
300 Rajab A, Straub V, McCann LJ, Seelow D, Varon R, Barresi R, Schulze A, Lucke B, Lützkendorf S, Karbasiyan M, Bachmann S, Spuler S, Schuelke M. Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations. PLoS Genet 2010;6:e1000874. [PMID: 20300641 DOI: 10.1371/journal.pgen.1000874] [Cited by in Crossref: 175] [Cited by in F6Publishing: 185] [Article Influence: 13.5] [Reference Citation Analysis]
301 Rubio-Cabezas O, Puri V, Murano I, Saudek V, Semple RK, Dash S, Hyden CS, Bottomley W, Vigouroux C, Magré J, Raymond-Barker P, Murgatroyd PR, Chawla A, Skepper JN, Chatterjee VK, Suliman S, Patch AM, Agarwal AK, Garg A, Barroso I, Cinti S, Czech MP, Argente J, O'Rahilly S, Savage DB; LD Screening Consortium. Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC. EMBO Mol Med 2009;1:280-7. [PMID: 20049731 DOI: 10.1002/emmm.200900037] [Cited by in Crossref: 192] [Cited by in F6Publishing: 198] [Article Influence: 14.8] [Reference Citation Analysis]
302 Debnath M, Prasad GB, Bisen PS. Molecular Diagnosis in the Post Genomic and Proteomic Era. Molecular Diagnostics: Promises and Possibilities 2010. [DOI: 10.1007/978-90-481-3261-4_7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
303 Grunberger G, Alfonso B. Syndromes of Extreme Insulin Resistance. Principles of Diabetes Mellitus 2010. [DOI: 10.1007/978-0-387-09841-8_17] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
304 Gao C, Mantzoros C. Lipodystrophy Syndromes. Endocrinology 2010. [DOI: 10.1016/b978-1-4160-5583-9.00038-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
305 Hupfeld CJ, Courtney CH, Olefsky JM. Type 2 Diabetes Mellitus. Endocrinology 2010. [DOI: 10.1016/b978-1-4160-5583-9.00041-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
306 Rao MN, Mulligan K, Schambelan M. HIV Infection and Diabetes. Principles of Diabetes Mellitus 2010. [DOI: 10.1007/978-0-387-09841-8_38] [Reference Citation Analysis]
307 Savage DB. Understanding Causal Relationships in the Metabolic Syndrome: Recent Insights from Extreme Human Phenotypes. Research and Perspectives in Endocrine Interactions 2010. [DOI: 10.1007/978-3-642-13517-0_13] [Reference Citation Analysis]
308 Ruderman N, Shulman GI. The Metabolic Syndrome. Endocrinology 2010. [DOI: 10.1016/b978-1-4160-5583-9.00044-7] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
309 Bocci V. The Clinical Application of Ozonetherapy. OZONE 2010. [DOI: 10.1007/978-90-481-9234-2_9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
310 Ambrus G, Gerace L. Signaling at the Nuclear Envelope. Handbook of Cell Signaling 2010. [DOI: 10.1016/b978-0-12-374145-5.00304-1] [Reference Citation Analysis]
311 Subramanyam L, Simha V, Garg A. Overlapping syndrome with familial partial lipodystrophy, Dunnigan variety and cardiomyopathy due to amino-terminal heterozygous missense lamin A/C mutations. Clin Genet 2010;78:66-73. [PMID: 20041886 DOI: 10.1111/j.1399-0004.2009.01350.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 2.6] [Reference Citation Analysis]
312 Aporntewan C, Ballard DH, Lee JY, Lee JS, Wu Z, Zhao H. Gene hunting of the Genetic Analysis Workshop 16 rheumatoid arthritis data using rough set theory. BMC Proc 2009;3 Suppl 7:S126. [PMID: 20017992 DOI: 10.1186/1753-6561-3-s7-s126] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
313 Herrero L, Shapiro H, Nayer A, Lee J, Shoelson SE. Inflammation and adipose tissue macrophages in lipodystrophic mice. Proc Natl Acad Sci USA. 2010;107:240-245. [PMID: 20007767 DOI: 10.1073/pnas.0905310107] [Cited by in Crossref: 121] [Cited by in F6Publishing: 122] [Article Influence: 8.6] [Reference Citation Analysis]
314 Keller J, Subramanyam L, Simha V, Gustofson R, Minjarez D, Garg A. Lipodystrophy: an unusual diagnosis in a case of oligomenorrhea and hirsutism. Obstet Gynecol 2009;114:427-31. [PMID: 19622949 DOI: 10.1097/AOG.0b013e31819feaa9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
315 Lanktree MB, Fantus IG, Hegele RA. Triple X syndrome in a patient with partial lipodystrophy discovered using a high-density oligonucleotide microarray: a case report. J Med Case Rep 2009;3:8867. [PMID: 19830242 DOI: 10.4076/1752-1947-3-8867] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
316 Kantartzis K, Totsikas C, Häring H, Stefan N. Role of ectopic fat in the pathogenesis of insulin resistance. Clinical Lipidology 2009;4:457-64. [DOI: 10.2217/clp.09.35] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
317 Reue K. The lipin family: mutations and metabolism. Curr Opin Lipidol. 2009;20:165-170. [PMID: 19369868 DOI: 10.1097/mol.0b013e32832adee5] [Cited by in Crossref: 81] [Cited by in F6Publishing: 86] [Article Influence: 5.8] [Reference Citation Analysis]
318 Lindgren CM, Heid IM, Randall JC, Lamina C, Steinthorsdottir V, Qi L, Speliotes EK, Thorleifsson G, Willer CJ, Herrera BM, Jackson AU, Lim N, Scheet P, Soranzo N, Amin N, Aulchenko YS, Chambers JC, Drong A, Luan J, Lyon HN, Rivadeneira F, Sanna S, Timpson NJ, Zillikens MC, Zhao JH, Almgren P, Bandinelli S, Bennett AJ, Bergman RN, Bonnycastle LL, Bumpstead SJ, Chanock SJ, Cherkas L, Chines P, Coin L, Cooper C, Crawford G, Doering A, Dominiczak A, Doney AS, Ebrahim S, Elliott P, Erdos MR, Estrada K, Ferrucci L, Fischer G, Forouhi NG, Gieger C, Grallert H, Groves CJ, Grundy S, Guiducci C, Hadley D, Hamsten A, Havulinna AS, Hofman A, Holle R, Holloway JW, Illig T, Isomaa B, Jacobs LC, Jameson K, Jousilahti P, Karpe F, Kuusisto J, Laitinen J, Lathrop GM, Lawlor DA, Mangino M, McArdle WL, Meitinger T, Morken MA, Morris AP, Munroe P, Narisu N, Nordström A, Nordström P, Oostra BA, Palmer CN, Payne F, Peden JF, Prokopenko I, Renström F, Ruokonen A, Salomaa V, Sandhu MS, Scott LJ, Scuteri A, Silander K, Song K, Yuan X, Stringham HM, Swift AJ, Tuomi T, Uda M, Vollenweider P, Waeber G, Wallace C, Walters GB, Weedon MN, Witteman JC, Zhang C, Zhang W, Caulfield MJ, Collins FS, Davey Smith G, Day IN, Franks PW, Hattersley AT, Hu FB, Jarvelin MR, Kong A, Kooner JS, Laakso M, Lakatta E, Mooser V, Morris AD, Peltonen L, Samani NJ, Spector TD, Strachan DP, Tanaka T, Tuomilehto J, Uitterlinden AG, van Duijn CM, Wareham NJ, Hugh Watkins, Waterworth DM, Boehnke M, Deloukas P, Groop L, Hunter DJ, Thorsteinsdottir U, Schlessinger D, Wichmann HE, Frayling TM, Abecasis GR, Hirschhorn JN, Loos RJ, Stefansson K, Mohlke KL, Barroso I, McCarthy MI; Wellcome Trust Case Control Consortium., Procardis Consortia., Giant Consortium. Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution. PLoS Genet 2009;5:e1000508. [PMID: 19557161 DOI: 10.1371/journal.pgen.1000508] [Cited by in Crossref: 368] [Cited by in F6Publishing: 396] [Article Influence: 26.3] [Reference Citation Analysis]
319 Mutimura E, Crowther NJ, Stewart A, Cade WT. The human immunodeficiency virus and the cardiometabolic syndrome in the developing world: an African perspective. J Cardiometab Syndr 2008;3:106-10. [PMID: 18453811 DOI: 10.1111/j.1559-4572.2008.07584.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
320 Tang J, Tan CY, Oresic M, Vidal-Puig A. Integrating post-genomic approaches as a strategy to advance our understanding of health and disease. Genome Med 2009;1:35. [PMID: 19341506 DOI: 10.1186/gm35] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
321 Cortés VA, Curtis DE, Sukumaran S, Shao X, Parameswara V, Rashid S, Smith AR, Ren J, Esser V, Hammer RE, Agarwal AK, Horton JD, Garg A. Molecular mechanisms of hepatic steatosis and insulin resistance in the AGPAT2-deficient mouse model of congenital generalized lipodystrophy. Cell Metab 2009;9:165-76. [PMID: 19187773 DOI: 10.1016/j.cmet.2009.01.002] [Cited by in Crossref: 177] [Cited by in F6Publishing: 180] [Article Influence: 12.6] [Reference Citation Analysis]
322 Semple RK, Sleigh A, Murgatroyd PR, Adams CA, Bluck L, Jackson S, Vottero A, Kanabar D, Charlton-Menys V, Durrington P. Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis. J Clin Invest. 2009;119:315-322. [PMID: 19164855 DOI: 10.1172/jci37432] [Cited by in Crossref: 37] [Cited by in F6Publishing: 139] [Article Influence: 2.6] [Reference Citation Analysis]
323 Garg A, Agarwal AK. Lipodystrophies: disorders of adipose tissue biology. Biochim Biophys Acta 2009;1791:507-13. [PMID: 19162222 DOI: 10.1016/j.bbalip.2008.12.014] [Cited by in Crossref: 126] [Cited by in F6Publishing: 138] [Article Influence: 9.0] [Reference Citation Analysis]
324 Phan J, Hickey MA, Zhang P, Chesselet MF, Reue K. Adipose tissue dysfunction tracks disease progression in two Huntington's disease mouse models. Hum Mol Genet 2009;18:1006-16. [PMID: 19124532 DOI: 10.1093/hmg/ddn428] [Cited by in Crossref: 91] [Cited by in F6Publishing: 94] [Article Influence: 6.5] [Reference Citation Analysis]
325 Joy TR, Hegele RA. Genetics of Metabolic Syndrome and Genetic Lipodystrophies. Diagnosis and Management of Polycystic Ovary Syndrome 2009. [DOI: 10.1007/978-0-387-09718-3_5] [Reference Citation Analysis]
326 Coleman S, Saboeiro A, Sengelmann R. A comparison of lipoatrophy and aging: volume deficits in the face. Aesthetic Plast Surg 2009;33:14-21. [PMID: 18987910 DOI: 10.1007/s00266-008-9258-z] [Cited by in Crossref: 49] [Cited by in F6Publishing: 33] [Article Influence: 3.5] [Reference Citation Analysis]
327 Hödl S. Diseases of Fat. Braun-Falco’s Dermatology 2009. [DOI: 10.1007/978-3-540-29316-3_73] [Reference Citation Analysis]
328 Qu H, Polychronakos C. The Genetic Basis of Diabetes. Diabetes in Women 2009. [DOI: 10.1007/978-1-60327-250-6_21] [Reference Citation Analysis]
329 Herranz P, de Lucas R, Pérez-España L, Mayor M. Lipodystrophy syndromes. Dermatol Clin 2008;26:569-78, ix. [PMID: 18793991 DOI: 10.1016/j.det.2008.05.004] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
330 Villena JA, Choi CS, Wang Y, Kim S, Hwang YJ, Kim YB, Cline G, Shulman GI, Sul HS. Resistance to high-fat diet-induced obesity but exacerbated insulin resistance in mice overexpressing preadipocyte factor-1 (Pref-1): a new model of partial lipodystrophy. Diabetes 2008;57:3258-66. [PMID: 18835937 DOI: 10.2337/db07-1739] [Cited by in Crossref: 65] [Cited by in F6Publishing: 69] [Article Influence: 4.3] [Reference Citation Analysis]
331 Reue K, Brindley DN. Thematic Review Series: Glycerolipids. Multiple roles for lipins/phosphatidate phosphatase enzymes in lipid metabolism. J Lipid Res. 2008;49:2493-2503. [PMID: 18791037 DOI: 10.1194/jlr.r800019-jlr200] [Cited by in Crossref: 138] [Cited by in F6Publishing: 144] [Article Influence: 9.2] [Reference Citation Analysis]
332 Simha V, Agarwal AK, Aronin PA, Iannaccone ST, Garg A. Novel subtype of congenital generalized lipodystrophy associated with muscular weakness and cervical spine instability. Am J Med Genet A 2008;146A:2318-26. [PMID: 18698612 DOI: 10.1002/ajmg.a.32457] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 2.6] [Reference Citation Analysis]
333 Shirwalkar HU, Patel ZM, Magre J, Hilbert P, Van Maldergem L, Mukhopadhyay RR, Maitra A. Congenital generalized lipodystrophy in an Indian patient with a novel mutation in BSCL2 gene. J Inherit Metab Dis 2008;31 Suppl 2:S317-22. [PMID: 18690553 DOI: 10.1007/s10545-008-0899-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
334 Yauger BJ, Gorden P, Park J, Cochran E, Stratton P. Effect of depot medroxyprogesterone acetate on glucose tolerance in generalized lipodystrophy. Obstet Gynecol 2008;112:445-7. [PMID: 18669758 DOI: 10.1097/AOG.0b013e3181662d17] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
335 Benhalima K, Mathieu C, Van Wijngaerden E. Disorders of glucose metabolism in human immunodeficiency virus-infected patients. Acta Clin Belg 2008;63:227-34. [PMID: 19048699 DOI: 10.1179/acb.2008.042] [Reference Citation Analysis]
336 Athanasiov PA, Prabhakaran VC, Selva D. Non-traumatic enophthalmos: a review. Acta Ophthalmol 2008;86:356-64. [PMID: 18462475 DOI: 10.1111/j.1755-3768.2007.01152.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 2.5] [Reference Citation Analysis]
337 Simha V, Garg A. Atypical Forms of Type 2 Diabetes. Type 2 Diabetes Mellitus. [DOI: 10.1007/978-1-60327-043-4_27] [Reference Citation Analysis]
338 Sterling RK, Contos MJ, Smith PG, Stravitz RT, Luketic VA, Fuchs M, Shiffman ML, Sanyal AJ. Steatohepatitis: Risk factors and impact on disease severity in human immunodeficiency virus/hepatitis C virus coinfection. Hepatology 2008;47:1118-27. [PMID: 18366118 DOI: 10.1002/hep.22134] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 3.4] [Reference Citation Analysis]
339 Sanal MG. The blind men ‘see’ the elephant-the many faces of fatty liver disease. World J Gastroenterol 2008; 14(6): 831-844 [PMID: 18240340 DOI: 10.3748/wjg.14.831] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
340 Schlegel A, Stainier DY. Lessons from "lower" organisms: what worms, flies, and zebrafish can teach us about human energy metabolism. PLoS Genet 2007;3:e199. [PMID: 18081423 DOI: 10.1371/journal.pgen.0030199] [Cited by in Crossref: 114] [Cited by in F6Publishing: 124] [Article Influence: 7.6] [Reference Citation Analysis]
341 Cao H, Alston L, Ruschman J, Hegele RA. Heterozygous CAV1 frameshift mutations (MIM 601047) in patients with atypical partial lipodystrophy and hypertriglyceridemia. Lipids Health Dis. 2008;7:3. [PMID: 18237401 DOI: 10.1186/1476-511X-7-3] [Cited by in Crossref: 100] [Cited by in F6Publishing: 108] [Article Influence: 6.7] [Reference Citation Analysis]
342 Cugnet C, Marcais C, Charrière S, Guitard-moret M, Decaudain A, Sassolas A, Moulin P. Génétique des hypertriglycéridémies. Médecine des Maladies Métaboliques 2008;2:15-22. [DOI: 10.1016/s1957-2557(08)70004-x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
343 Lustig RH, Weiss R. Disorders of Energy Balance. Pediatric Endocrinology 2008. [DOI: 10.1016/b978-141604090-3.50024-7] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
344 Szymanski KM, Binns D, Bartz R, Grishin NV, Li WP, Agarwal AK, Garg A, Anderson RG, Goodman JM. The lipodystrophy protein seipin is found at endoplasmic reticulum lipid droplet junctions and is important for droplet morphology. Proc Natl Acad Sci U S A 2007;104:20890-5. [PMID: 18093937 DOI: 10.1073/pnas.0704154104] [Cited by in Crossref: 452] [Cited by in F6Publishing: 470] [Article Influence: 28.3] [Reference Citation Analysis]
345 Congenital Generalized Lipodystrophy. Atlas of Genetic Diagnosis and Counseling. [DOI: 10.1007/978-1-60327-161-5_40] [Reference Citation Analysis]
346 Reue K, Zhang P. The lipin protein family: dual roles in lipid biosynthesis and gene expression. FEBS Lett. 2008;582:90-96. [PMID: 18023282 DOI: 10.1016/j.febslet.2007.11.014] [Cited by in Crossref: 146] [Cited by in F6Publishing: 152] [Article Influence: 9.1] [Reference Citation Analysis]
347 Simha V, Agarwal AK. Inherited and Acquired Lipodystrophies. Nutrition and Health. [DOI: 10.1007/978-1-59745-370-7_18] [Reference Citation Analysis]
348 Steinmetz A, Schmidt H. Glykogenspeichererkrankungen, Lipodystrophien und andere Fettgewebserkrankungen. Medizinische Therapie 2007 | 2008. [DOI: 10.1007/978-3-540-48554-4_42] [Reference Citation Analysis]
349 Park JY, Chong AY, Cochran EK, Kleiner DE, Haller MJ, Schatz DA, Gorden P. Type 1 diabetes associated with acquired generalized lipodystrophy and insulin resistance: the effect of long-term leptin therapy. J Clin Endocrinol Metab 2008;93:26-31. [PMID: 17940115 DOI: 10.1210/jc.2007-1856] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 3.3] [Reference Citation Analysis]
350 Lüdtke A, Buettner J, Schmidt HH, Worman HJ. New PPARG mutation leads to lipodystrophy and loss of protein function that is partially restored by a synthetic ligand. J Med Genet 2007;44:e88. [PMID: 17766367 DOI: 10.1136/jmg.2007.050567] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 1.8] [Reference Citation Analysis]
351 Ohara T. Diabetes. Cachexia and Wasting: A Modern Approach. [DOI: 10.1007/978-88-470-0552-5_28] [Reference Citation Analysis]
352 Scevola D, Giglio O, Scevola S. Treatment of AIDS Anorexia-Cachexia Syndrome and Lipodystrophy. Cachexia and Wasting: A Modern Approach. [DOI: 10.1007/978-88-470-0552-5_41] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
353 Kim S, Huang LW, Snow KJ, Ablamunits V, Hasham MG, Young TH, Paulk AC, Richardson JE, Affourtit JP, Shalom-Barak T, Bult CJ, Barak Y. A mouse model of conditional lipodystrophy. Proc Natl Acad Sci U S A 2007;104:16627-32. [PMID: 17921248 DOI: 10.1073/pnas.0707797104] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 1.8] [Reference Citation Analysis]
354 Albu JB, Kenya S, He Q, Wainwright M, Berk ES, Heshka S, Kotler DP, Engelson ES. Independent associations of insulin resistance with high whole-body intermuscular and low leg subcutaneous adipose tissue distribution in obese HIV-infected women. Am J Clin Nutr 2007;86:100-6. [PMID: 17616768 DOI: 10.1093/ajcn/86.1.100] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 1.6] [Reference Citation Analysis]
355 Méas T, Laloi-michelin M, Virally M, Médeau V, Kévorkian J, Guillausseau P. Diabète lipoatrophique acquis. Médecine des Maladies Métaboliques 2007;1:57-58. [DOI: 10.1016/s1957-2557(07)91999-9] [Reference Citation Analysis]
356 Vega GL, Chandalia M, Szczepaniak LS, Grundy SM. Metabolic correlates of nonalcoholic fatty liver in women and men. Hepatology 2007;46:716-22. [PMID: 17659597 DOI: 10.1002/hep.21727] [Cited by in Crossref: 63] [Cited by in F6Publishing: 57] [Article Influence: 3.9] [Reference Citation Analysis]
357 Wang CP, Chung FM, Shin SJ, Lee YJ. Congenital and environmental factors associated with adipocyte dysregulation as defects of insulin resistance. Rev Diabet Stud 2007;4:77-84. [PMID: 17823691 DOI: 10.1900/RDS.2007.4.77] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
358 Hegele RA. Copy-number variations and human disease. Am J Hum Genet 2007;81:414-5; author reply 415. [PMID: 17668391 DOI: 10.1086/519220] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
359 Lichtenstein K, Balasubramanyam A, Sekhar R, Freedland E. HIV-associated adipose redistribution syndrome (HARS): definition, epidemiology and clinical impact. AIDS Res Ther 2007;4:16. [PMID: 17634130 DOI: 10.1186/1742-6405-4-16] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
360 Bilz S, Keller U. Fettleber und Lipidstoffwechsel. Diabetologe 2007;3:184-191. [DOI: 10.1007/s11428-007-0129-z] [Reference Citation Analysis]
361 Savage DB, Petersen KF, Shulman GI. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev. 2007;87:507-520. [PMID: 17429039 DOI: 10.1152/physrev.00024.2006] [Cited by in Crossref: 713] [Cited by in F6Publishing: 738] [Article Influence: 44.6] [Reference Citation Analysis]
362 Sweeney LL, Brennan AM, Mantzoros CS. The role of adipokines in relation to HIV lipodystrophy. AIDS 2007;21:895-904. [PMID: 17457082 DOI: 10.1097/QAD.0b013e3280adc91e] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 2.5] [Reference Citation Analysis]
363 Rubio Cabezas O, Argente Oliver J. [Diabetes mellitus in children: a heterogeneous disease]. Med Clin (Barc) 2007;128:627-33. [PMID: 17524322 DOI: 10.1157/13101746] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
364 Park JY, Javor ED, Cochran EK, DePaoli AM, Gorden P. Long-term efficacy of leptin replacement in patients with Dunnigan-type familial partial lipodystrophy. Metabolism 2007;56:508-16. [PMID: 17379009 DOI: 10.1016/j.metabol.2006.11.010] [Cited by in Crossref: 71] [Cited by in F6Publishing: 76] [Article Influence: 4.4] [Reference Citation Analysis]
365 Heikkinen S, Auwerx J, Argmann CA. PPARgamma in human and mouse physiology. Biochim Biophys Acta 2007;1771:999-1013. [PMID: 17475546 DOI: 10.1016/j.bbalip.2007.03.006] [Cited by in Crossref: 161] [Cited by in F6Publishing: 168] [Article Influence: 10.1] [Reference Citation Analysis]
366 Toledo FGS, Kelley DE. Ectopic Fat and the Metabolic Syndrome. Overweight and the Metabolic Syndrome. [DOI: 10.1007/978-0-387-32164-6_7] [Reference Citation Analysis]
367 Casademont J. [Dermatomyositis, lipodystrophy and insulin resistance]. Med Clin (Barc) 2007;128:76-7. [PMID: 17266906 DOI: 10.1016/s0025-7753(07)72490-9] [Reference Citation Analysis]
368 Carr A, Ory D. Does HIV cause cardiovascular disease? PLoS Med 2006;3:e496. [PMID: 17132070 DOI: 10.1371/journal.pmed.0030496] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
369 Greaves P. Integumentary System. Histopathology of Preclinical Toxicity Studies 2007. [DOI: 10.1016/b978-044452771-4/50003-1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
370 Arimura T, Kurano M, Saito N, Nagasaki H, Tanoue E, Sameshima H, Kamada T, Kikuchi A, Kamikubo T, Tsubouchi H. Congenital Generalized Lipodystrophy with Diabetic Triopathy. J Jpn Soc Intern Med 2007;96:2279-2281. [DOI: 10.2169/naika.96.2279] [Reference Citation Analysis]
371 Labossiere R, Goldberg IJ. Management of Hypertriglyceridemia. Therapeutic Lipidology 2007. [DOI: 10.1007/978-1-59745-533-6_10] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
372 Costs, Pathology, and Health Risks of Obesity and the Metabolic Syndrome. The Metabolic Syndrome and Obesity 2007. [DOI: 10.1007/978-1-59745-431-5_3] [Reference Citation Analysis]
373 Ahima RS, Jackson MB. Lipodystrophy: The experiment of nature to study leptin. Leptin. [DOI: 10.1007/978-0-387-31416-7_12] [Reference Citation Analysis]
374 Capeau J, Magré J, Caron M, Lagathu C, Bastard J, Vigouroux C. Genetic and acquired lipodystrophies: from fat redistribution to insulin resistance and aging. Future Lipidology 2006;1:593-604. [DOI: 10.2217/17460875.1.5.593] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
375 Al-Attar SA, Pollex RL, Robinson JF, Miskie BA, Walcarius R, Rutt BK, Hegele RA. Semi-automated segmentation and quantification of adipose tissue in calf and thigh by MRI: a preliminary study in patients with monogenic metabolic syndrome. BMC Med Imaging 2006;6:11. [PMID: 16945131 DOI: 10.1186/1471-2342-6-11] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 1.3] [Reference Citation Analysis]
376 Ranganathan G, Unal R, Pokrovskaya I, Yao-Borengasser A, Phanavanh B, Lecka-Czernik B, Rasouli N, Kern PA. The lipogenic enzymes DGAT1, FAS, and LPL in adipose tissue: effects of obesity, insulin resistance, and TZD treatment. J Lipid Res. 2006;47:2444-2450. [PMID: 16894240 DOI: 10.1194/jlr.m600248-jlr200] [Cited by in Crossref: 129] [Cited by in F6Publishing: 132] [Article Influence: 7.6] [Reference Citation Analysis]
377 Giralt M, Domingo P, Guallar JP, de la Concepción MLR, Alegre M, Domingo JC, Villarroya F. HIV-1 Infection Alters Gene Expression in Adipose Tissue, Which Contributes to HIV-1/Haart-Associated Lipodystrophy. Antiviral Therapy 2006;11:729-740. [DOI: 10.1177/135965350601100610] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
378 Hegele RA, Cao H, Liu DM, Costain GA, Charlton-Menys V, Rodger NW, Durrington PN. Sequencing of the reannotated LMNB2 gene reveals novel mutations in patients with acquired partial lipodystrophy. Am J Hum Genet 2006;79:383-9. [PMID: 16826530 DOI: 10.1086/505885] [Cited by in Crossref: 153] [Cited by in F6Publishing: 155] [Article Influence: 9.0] [Reference Citation Analysis]
379 Ascher B, Coleman S, Alster T, Bauer U, Burgess C, Butterwick K, Donofrio L, Engelhard P, Goldman MP, Katz P, Vleggaar D. Full Scope of Effect of Facial Lipoatrophy. Dermatologic Surgery 2006;32:1058-1069. [DOI: 10.1097/00042728-200608000-00012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
380 Hansen E, Hajri T, Abumrad NN. Is all fat the same? The role of fat in the pathogenesis of the metabolic syndrome and type 2 diabetes mellitus. Surgery 2006;139:711-6. [PMID: 16782424 DOI: 10.1016/j.surg.2005.10.018] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 1.4] [Reference Citation Analysis]
381 Vidal A, Alonso M. [Dermatomyositis, lipodystrophy and insulin resistance]. Med Clin (Barc) 2006;126:515. [PMID: 16624235 DOI: 10.1157/13086854] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
382 Sáenz de Navarrete G, Mesa J, Lecube A. Lipodistrofia parcial familiar, variedad de Dunnigan: alteración fenotípica unida a síndrome metabólico. Medicina Clínica 2006;126:597-598. [DOI: 10.1157/13087692] [Reference Citation Analysis]
383 Steinmetz A, Schmidt H. Glykogenspeichererkrankungen, Lipodystrophien und andere Fettgewebserkrankungen. Medizinische Therapie 2005|2006. [DOI: 10.1007/3-540-27385-9_42] [Reference Citation Analysis]
384 Tsiodras S, Mantzoros C. Leptin and Adiponectin in the HIV Associated Metabolic Syndrome: Physiologic and Therapeutic Implications. Am J Infect Dis 2006;2:141-52. [PMID: 17183414 DOI: 10.3844/ajidsp.2006.141.152] [Cited by in Crossref: 28] [Cited by in F6Publishing: 34] [Article Influence: 1.6] [Reference Citation Analysis]
385 Beigneux AP, Vergnes L, Qiao X, Quatela S, Davis R, Watkins SM, Coleman RA, Walzem RL, Philips M, Reue K, Young SG. Agpat6--a novel lipid biosynthetic gene required for triacylglycerol production in mammary epithelium. J Lipid Res 2006;47:734-44. [PMID: 16449762 DOI: 10.1194/jlr.M500556-JLR200] [Cited by in Crossref: 91] [Cited by in F6Publishing: 99] [Article Influence: 5.4] [Reference Citation Analysis]
386 Henry RR, Phillips SA, Mudaliar SR, Ciaraldi TP. Chapter 6 The adipocyte and adipose tissue as endocrine organs: Impact on the insulin resistance phenotype. New Transcription Factors and their Role in Diabetes and its Therapy 2006. [DOI: 10.1016/s1569-2566(06)05006-x] [Reference Citation Analysis]
387 Scevola D, Di Matteo A, Giglio O, Uberti F. HIV Infection-Related Cachexia and Lipodystrophy. Cachexia and Wasting: A Modern Approach 2006. [DOI: 10.1007/978-88-470-0552-5_40] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
388 Neuschwander-tetri BA. NASH. Zakim and Boyer's Hepatology 2006. [DOI: 10.1016/b978-1-4160-3258-8.50060-7] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
389 Mitchell CS, Gurnell M. Chapter 2 PPARγ, a key therapeutic target in the metabolic syndrome – unique insights derived from the study of human genetic variants. New Transcription Factors and their Role in Diabetes and its Therapy 2006. [DOI: 10.1016/s1569-2566(06)05002-2] [Reference Citation Analysis]
390 Boccara F, Cohen A. Coronary Artery Disease in HIV-Infected Patients: Clinical Presentation, Pathophysiology, Prognosis, Prevention, and Treatment. Cardiovascular Disease in AIDS. [DOI: 10.1007/88-470-0358-x_6] [Reference Citation Analysis]
391 Hadigan C, Kamin D, Liebau J, Mazza S, Barrow S, Torriani M, Rubin R, Weise S, Fischman A, Grinspoon S. Depot-specific regulation of glucose uptake and insulin sensitivity in HIV-lipodystrophy. Am J Physiol Endocrinol Metab 2006;290:E289-98. [PMID: 16131513 DOI: 10.1152/ajpendo.00273.2005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.2] [Reference Citation Analysis]
392 Hödl S. Erkrankungen des Fettgewebes. Dermatologie und Venerologie. [DOI: 10.1007/3-540-26624-0_67] [Reference Citation Analysis]
393 Chao PJ, Tsai JC, Chang DM, Shin SJ, Lee YJ. A case of acquired generalized lipodystrophy with cerebellar degeneration and type 2 diabetes mellitus. Rev Diabet Stud 2004;1:193-7. [PMID: 17491704 DOI: 10.1900/RDS.2004.1.193] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
394 Grundy SM. Metabolic syndrome: therapeutic considerations. Handb Exp Pharmacol 2005;:107-33. [PMID: 16596797 DOI: 10.1007/3-540-27661-0_3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 1.0] [Reference Citation Analysis]
395 Shuldiner AR, McLenithan JC. Genes and pathophysiology of type 2 diabetes: more than just the Randle cycle all over again. J Clin Invest 2004;114:1414-7. [PMID: 15545992 DOI: 10.1172/JCI23586] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 0.1] [Reference Citation Analysis]
396 Hegele RA. Treatment of partial lipodystrophy: can the zebra teach us about the horse? Drug Discovery Today: Disease Mechanisms 2004;1:195-203. [DOI: 10.1016/j.ddmec.2004.09.009] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
397 Ristow M. Neurodegenerative disorders associated with diabetes mellitus. J Mol Med (Berl) 2004;82:510-29. [PMID: 15175861 DOI: 10.1007/s00109-004-0552-1] [Cited by in Crossref: 229] [Cited by in F6Publishing: 242] [Article Influence: 12.1] [Reference Citation Analysis]
398 Legro RS. Phenotype and genotype in polycystic ovary syndrome. Polycystic Ovary Syndrome 2001. [DOI: 10.1017/cbo9780511545191.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]